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ABSTRACT 
 
The aim of this study was to assess community members’ knowledge levels regarding Drug 
Resistant TB and HIV and AIDS. The study was conducted at ward 40 in Green bushes area 
in Nelson Mandela Metropolitan Municipality (NMMM). A quantitative research method 
was used in this study. Random sampling is the type of probability sampling method that was 
used in this study. The sample consisted of 100 respondents above 18 years who were 
randomly selected from the beneficiary list of for the RDP houses in Green bushes area in the 
Nelson Mandela Metropolitan Municipality. Data for this study were collected using close 
ended questions which were administered by the researcher to the selected participants. Data 
was analysed using bivariate and descriptive statistics according to the identified themes.  
 
The study revealed that community members had high knowledge levels regarding Drug 
Resistant TB and HIV and AIDS prevention, transmission modes and diagnosis and treatment 
methods. The findings revealed that community members were highly knowledgeable and 
aware of the fact that abstaining and practising safe sex were means of preventing the spread 
of HIV and AIDS as it was spread through unprotected sex, while opening of windows and 
minimisation of close contact with HIV positive people and children with people infected 
with Drug Resistant TB are infection control measures or methods of preventing the spread of 
the disease.  
 
Additionally, the study indicated that female respondents were more aware and 
knowledgeable about prevention, transmission modes and diagnosis and treatment of Drug 
Resistant TB and HIV and AIDS than male respondents. Furthermore, the findings revealed 
that the respondents were highly knowledgeable and aware about transmission of Drug 
Resistant TB and HIV and AIDS; knowledgeable about prevention and less knowledgeable 
about diagnosis and treatment. A high percentage of female respondents knew that there was 
no vaccine to neither prevent nor cure HIV and AIDS and that antiretroviral drug were used 
to manage it.  
 
The study also showed that female respondents knew that all people irrespective of race and 
economic class can be infected with Drug Resistant TB and HIV and AIDS. It is important to 
note that the respondents between 41-60 years possessed more knowledge regarding Drug 
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Resistant TB and HIV and AIDS than the respondents who were between 18-40 years. 
 
Lastly, the study showed that there were significant differences in gender and knowledge and 
no significant differences in age and knowledge of the respondents regarding Drug Resistant 
TB and HIV and AIDS. It is recommended that in future, research regarding knowledge 
levels about Drug Resistant TB and HIV and AIDS be extended to other wards in the Nelson 
Mandela Metropolitan Municipality (NMMM). Accurate knowledge should be provided by 
ensuring that educational materials that are developed, are appropriate for the various levels 
of literacy, and that more appropriate and relevant information regarding these diseases is 
made more accessible to community members in their home languages. The researcher 
further recommends that during training interventions and educational campaigns more 
emphasis should be put on prevention, diagnosis and treatment of Drug Resistant TB and 
HIV and AIDS. 
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 CHAPTER 1 
 
 INTRODUCTION, PROBLEM STATEMENT AND OUTLINE OF THE 
RESEARCH STUDY 
 
1.1 Introduction 
 
The Human immunodeficiency virus or Acquired immune deficiency syndrome 
(HIV and AIDS) was first identified in 1981. Since then the epidemic has become 
a serious health and development problem in many countries around the world. At 
the end of the 2009 the Joint United Nations Program on AIDS (UNAIDS) 
estimated the number of HIV infection worldwide at about 33.4 million. About 
22, 4 million infected people which are 67% of the total infections were in Sub- 
Saharan Africa, 68% of new HIV infection among adults and 91% of new 
infections on children. The region also accounted for 72% of the world’s AIDS 
related deaths in 2008 (UNAIDS, 2009). This study tries to assess the Drug 
Resistant Tuberculosis (DR-TB) and HIV and AIDS knowledge levels among 
community members in Nelson Mandela Metropolitan Municipality - Eastern 
Cape Province in South Africa. 
 
South Africa has the largest number of HIV and AIDS infected people in the 
world (UNAIDS, 2009). The HIV and AIDS prevalence in the Eastern Cape was 
29.9% just below the national prevalence of the country which was 30.2% in 2010 
(www.avert.org).  
 
The Nelson Mandela Metro District has the highest HIV prevalence rate than 
other districts in the Eastern Cape over the period of three years (31.9% in 2006, 
28.9 % in 2007 and 29% in 2008). 
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 South Africa is further burdened by Tuberculosis (TB) as its TB rate is double 
than those found in the other developing countries. The numbers of Multi Drug 
Resistant-TB (MDR-TB) and Extreme Drug Resistant – TB (XDR-TB) patients 
have increased due to the concurrent HIV epidemic and inadequate management 
of TB. In 2009 the National Health Laboratory Services diagnosed 9 070 MDR-
TB and 594 XDR-TB cases.  
 
There has been a steady increase in cases since 2006, possibly due to increased 
case detection. In 2010 the National Health Laboratory Services diagnosed 7 386 
Multi Drug Resistant TB cases and 741 Extreme Drug Resistant TB cases and 
these figures exclude diagnoses that are made through private laboratories as they 
are not known in the country (South African National Department of Health, 
2011). 
 
According to the report released by the National Health Laboratory Services 
South Africa have 45196 patients of Multi Drug Resistant and 3128 Extreme 
Drug Resistant TB patients from 2004 to 2010. Kwa-Zulu Natal is currently 
occupying the first spot with 11393 followed in the second position by the 
Western Cape with 10947 and Eastern Cape in the third position with 7993 Multi 
Drug Resistant TB patients. The Eastern Cape replaces the Western Cape on the 
second position with 808 patients and the Western Cape moves up to the third 
position with only 342 patients when it comes to Extreme Drug Resistant TB 
patients while Kwa-Zulu Natal continues to hold the first position with 1499 
patients (South African National Department of Health, 2011). 
 
These two diseases pose a serious threat to the economic, health and world 
development initiatives as they mainly affect people between ages 15 to 49 who 
are economically active. HIV and AIDS together with Drug Resistant TB strains 
Multi and Extreme Drug Resistant Tuberculosis (MDR and XDR TB) are 
spreading very fast and are continuing to bring the worst and the best out of 
communities. 
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 They bring the best when communities came together and mobilize themselves to 
take action against HIV and AIDS and DR-TB. On the other hand they bring the 
worst when the community does not treat those infected with love, respect and 
dignity or when they are abused, ridiculed, marginalized and rejected even worse 
by their families, friends and loved ones (Mashabela, 2006).  
 
In South Africa, the National TB Program initially required hospitalization of all 
Drug Resistant TB patients for an initial period of six months as required by the 
South African National Department of Health (South African National 
Department of Health, 2011). A clinical review of the DR-TB services revealed 
that the TB management program is currently facing many challenges including 
delayed treatment initiation, inadequate bed capacity, and poor infection control 
in hospital and poor adherence in treatment. To address these challenges, the 
length of time that MDR-TB patients are required to stay in centralised DR-TB 
hospitals was reduced, and a decision made to decentralise and deinstitutionalise 
services (South African National Department of Health, 2011). 
 
It has been stated that holding patients against their will is illegal and it is not 
guarantee that patients will indeed heal or be cured from their illness. It is stated 
that under certain circumstances it better to treat people infected at home where 
they are not congested in small or overcrowded wards with full support of their 
families (www.britannica.com). 
 
According to Nordell and Dharmadhikari (2010) the implementation of the 
decentralised care model will improve efficiency and effectiveness of the DR TB 
and HIV and AIDS management, if all the relevant stakeholders are playing their 
role. Key to the successful decentralisation and deinstitutionalisation and effective 
DR TB and HIV and AIDS programs is effective infection control, effective DR 
TB and HIV and AIDS advocacy, communication and social mobilisation at 
community level.  
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 DR TB is managed at three levels namely, tertiary levels, primary health centres 
and at the community level. Community and family members need to be well 
informed about the diseases so that they can be in a position to provide emotional 
support, nursing care to the patients during treatment, help with early 
identification and reporting of changes in patient’s conditions to the clinic nurse 
or the community care giver (South African National Department of Health, 
2011). In the Eastern Cape, people who are infected with Drug Resistant 
Tuberculosis (DR TB) are admitted to Jose Pearson and Fort Grey MDR and 
XDR TB Hospitals up until such time that they are certified to be un-infectious. 
The hospitalization of patients for the minimum of six months forced patients to 
relinquish their work, home and family responsibilities.  
 
In 2008 and 2009 patients at Jose Pearson TB Hospital ran away from the hospital 
to spent time with their families. They used their illness to scare off staff and 
security guards. The Eastern Cape Department of Health applied for a court order 
to get them sent back to the hospital as it was stated that they were highly 
infectious and a danger to the society as a whole. This raised fears and concerns 
from all stakeholders in the society. Stigmatization and discrimination towards 
people living with drug resistant TB also increased as people feared of getting 
infected. The situation went bad to such an extent that some family members were 
refusing to allow their relatives back home even when they were discharged from 
the hospital because of fear of getting infected (Ngcebetsha, 2011).  
 
According to Anon (2003) the general awareness of the DR TB and HIV and 
AIDS issue must be increased in order for people to understand how to protect 
themselves, reduce the stigmatization of and discrimination against those that are 
infected by these diseases and ultimately bring the HIV and AIDS and DR TB 
crisis under control. Overcoming stigma and discrimination is the key to 
mitigating the effects of DR TB and HIV and AIDS and as society becomes more 
accepting of people with these diseases, they will be more open and responsive to 
education and lifestyle changes (Anon, 2003). 
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 The above and the following are some of the factors that have motivated the 
author to conduct this study. The researcher is currently working in a DR TB 
Hospital. The hospital is situated between Greenbushes and Bethelsdorp and some 
of the patients admitted in the hospital are from the surrounding areas. The 
effective and efficient management of DR TB and HIV and AIDS programs 
requires infection control, effective DR TB and HIV and AIDS advocacy, 
communication, social mobilisation at community level, with the view of 
empowering people with relevant factual information about the diseases and 
dispel stigma surrounding these diseases in the community. It is on the basis of 
the above that the author had decided to assess the community members Drug 
Resistant TB and HIV and AIDS knowledge levels. 
 
1.2 Rationale for the Study 
 
This study intends to establish the knowledge levels of the community members 
of Ward 40 in the Nelson Mandela Metropolitan Municipality regarding Drug 
Resistant TB and HIV and AIDS. The Nelson Mandela Metro District has the 
highest HIV prevalence rate than other districts in the Eastern Cape over the 
period of three years (31.9% in 2006, 28.9 % in 2007 and 29% in 2008). The 
NMMM was also declared as having crisis with regard to TB in 2011. The 
objectives of TB and HIV and AIDS education campaigns are to educate and 
empower communities with regard issues relating prevention, transmission, 
diagnosis and treatment or care and support when infected or affected by these 
diseases. Stigma, ill-treatment and discrimination of people infected with DR TB 
and HIV and AIDS even after being discharged from DR TB hospitals is an 
indication of the failure to achieve the objectives of the education campaigns.  
 
This study is therefore intended at establishing whether the community members 
at Ward 40 have got the appropriate knowledge and awareness with regard to 
prevention, transmission, diagnosis and treatment of Drug Resistant TB and HIV 
and AIDS. 
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 Control and prevention of TB and HIV and AIDS is one of the United Nations 
Millennium Development Goals. South Africa is one of the countries that are 
working towards achievement of the Millennium Development Goals. This study 
intends to make recommendations towards TB and HIV and AIDS program 
design and delivery which will in turn contribute towards increasing knowledge 
about prevention, management and control of these infectious diseases. 
 
1.3 Research Problem 
 
South Africa has the highest number of HIV and AIDS infected people in the 
world. South Africa is ranked number three (3) by the World Health Organization, 
among highest TB burdened countries in the world after China and India 
(Department of Health, 2011). With the identification of MDR and XDR TB the 
well-being of people was further threatened. Those infected with HIV and AIDS 
run the risks of being co-infected with these resistant strains of TB (Ndabeni, 
2011).  
 
They further find themselves in a very difficult and serious situation. While faced 
with death from the disease they are still abused, ridiculed and marginalized. They 
are not treated with love, respect and dignity once their diagnosis or status is 
publicly known. They are discriminated, rejected and unfairly treated by their 
colleagues at work, families and community members at large (Anon, 2003 and 
Tlou*, 2006). This study tries to establish DR TB and HIV and AIDS knowledge 
levels among community members in NMMM. 
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1.4 Research Questions 
 
1.4.1 Main question 
 
What are the community member’s knowledge levels regarding Drug Resistant 
TB and HIV and AIDS? 
 
1.4.2 Sub questions 
 
1. What are the community member’s knowledge level regarding Drug Resistant 
TB and HIV and AIDS? 
2. Are there any gender related differences in the Drug Resistant TB and HIV 
and AIDS knowledge levels of the community members?  
3. Are there any age related differences in the Drug Resistant TB and HIV and 
AIDS knowledge levels of the community members? 
 
1.5 Aim and objectives of the study 
 
The main aim of this study is to assess the Drug Resistant TB and HIV and AIDS 
knowledge levels among community members in Nelson Mandela Metropolitan 
Municipality – Eastern Cape Province in South Africa. 
 
 Objectives of Research 
 
1. Assess Drug Resistant TB and HIV and AIDS knowledge levels of the 
community members in Nelson Mandela Metropolitan Municipality. 
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2. Assess whether there are any gender related differences in the Drug 
Resistant TB and HIV and AIDS knowledge levels of the community 
members in NMMM.  
3. Assess whether there are any age related difference in Drug Resistant TB 
and HIV and AIDS knowledge levels of the community members in 
NMMM. 
 
1.6 Delimitation of the study 
 
In order to make the study more manageable for the researcher, the study will 
focus on the following: 
 
The study will focus on the residents of Ward 40 in Greenbushes in the NMMM 
which is made up of the town of Port Elizabeth, Dispatch and Uitenhage. 
 
1.7  Significance of the study 
 
This research is of significance as it can provide useful information that can be 
used to inform program design. It will also help to inform program designers of 
the type of information that should be disseminated during education and 
awareness campaigns both to the community and the affected families. This 
research tries to establish whether community members have got the right 
knowledge about Drug Resistant TB and HIV and AIDS.  
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 1.8 Layout of the study 
 
In chapter one, the problem statement and research question is presented with the 
aims and the objectives of the research, delimitation, significance. In chapter two 
key concepts, issues, together with management and legal aspects regarding HIV 
and AIDS and DR TB are discussed. In chapter three the researcher outlines the 
research methodology that was applied in the collection and analysis of data. In 
chapter four the results of the empirical study are presented and discussed. In 
chapter five the summary of the findings is given, conclusions are drawn, 
limitations of the study are outlined and recommendations are made.  
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 CHAPTER 2 
 
 LITERATURE REVIEW 
 
2.1 Introduction 
 
This chapter reviews literature pertinent to Drug Resistant Tuberculosis and HIV 
and AIDS. The chapter explores Drug Resistant TB and HIV and AIDS around 
the world in order to give a picture on the extent of these diseases. The chapter 
discusses issues concerning the prevention, transmission, diagnoses and treatment 
and the legal and ethical aspects in management of Extreme and Multiple Drug 
Resistant Tuberculosis and HIV and AIDS. The chapter further discusses studies 
that deal with knowledge about the Drug Resistant TB and HIV and AIDS.  
 
The studies reviewed included those that assessed TB and Drug Resistant TB 
knowledge, attitudes and practices between healthcare workers, physicians, 
private and public sector  doctors (Vandan, Prasad and Kuroiwa, 2009; Al-Maniri, 
Al-Rawas, Al-Amji, De Costa, Erikson and Diwan, 2008; Savicevic, 2009; Hoa 
and Thornson, 2005; Hasim, Kubaisy and Dulayme, 2003). Studies conducted in 
Africa included those which were conducted by (Gibson, Cane, Doering and 
Harns, 2005; Naidoo, Taylor and Jinabhal, 2007; Loveday, Thomas, Chorpa and 
Ndlela, 2008; Ndoro, 2009; Adebanjo, 2011). 
 
Second group of studies that were consulted involved those that dealt with 
assessment of community members HIV and AIDS knowledge levels and 
attitudes towards people living with HIV and AIDS. This group consisted of the 
studies by the following (Coetzee, 2002; Strydom, 2002; Pirie and Coetzee, 2009; 
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 Cornelissen, 2006; Tee and Huang, 2009; Shipolono, 2009; Onyango, 2011; Phiri, 
Ngcakaza and Ncayo, 2012). 
 
2.2 Issues related to HIV and AIDS 
 
This section has three important sub-sections. The first sub-section provides an 
understanding of HIV and AIDS. The second sub-section discusses about 
diagnosing HIV and AIDS. The third sub-section looks at HIV and AIDS 
transmission.   
2.2.1 An understanding of Human Immunodeficiency Virus and Acquired 
Immunodeficiency Syndrome 
 
HIV is a retro-virus that contains RNA and three types of retro-viruses are 
identified. HIV is a lentivirus, which means that is has a slow, long-term effect. 
The first cases of AIDS were reported in the USA in 1981 when an unusual lung 
infection was seen in men who had sex with other men (Van Zyl, 2011). 
According to Cornelissen (2006) AIDS was first thought to be specific to 
homosexuals and was initially called Gay-Related Immune Deficiency Syndrome 
(GRID). Investigations into the cause of AIDS focused on the perceived lifestyle 
of homosexuals, including suggestions that drug use and overexposure to semen 
were causes of AIDS. In 1982, the first cases of AIDS were found in 
haemophiliacs and the differences in lifestyles of homosexuals and haemophiliacs 
led scientists to look for other causes of the disease, which led to the isolation of 
the HI Virus, which is the precursor to AIDS. In 1984 the HIV1 virus was 
identified while the HIV2 virus was identified in 1985 in Africa (Ngcakaza, 
2012). 
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 Factors that led to the rapid spread of the virus include the role of international 
travel. Patient Zero, who had AIDS and was a Canadian flight attendant, travelled 
extensively worldwide and early cases of AIDS showed a link to the flight 
attendant and those affected, leading to the conclusion that international travel had 
an effect on the transmission of the virus. Blood transfusions are also attributed to 
the spread of HIV and AIDS.  The routinized use of blood transfusions in the 
USA, as well as donors who were intravenous drug users being paid to donate 
blood, led to the spread of the virus. Lastly, an increase in the use and availability 
of heroin in the 1970s, as well as the accessibility and sharing of disposable 
plastic syringes, opened another route through which the virus could be spread 
(Ncayo, 2012).  
 
Cornelissen (2006) stated that diseases and poverty are widespread in South 
Africa and these are key factors that are contributing to the rapid spread of HIV. 
Loss of income due to medical and funeral expenses impacts on households. The 
financial impact of HIV and AIDS on a household has been shown to be 30% 
more than deaths arising from other causes. Professional health services are not 
freely available and the burden of caring for those that are infected rests with the 
family. 
 
Gender inequalities have also contributed to the fast spread of HIV and AIDS. 
South Africa has the highest level of rape in the world for a country that is not at 
war. Women are infected through rape and sometimes unable to access drugs to 
prevent HIV infection. The HIV and AIDS epidemic is mainly driven by the 
interaction of gender, sex and power relations. The effects of traditional 
masculine roles and behaviours, including men having power over women, having 
multiple sexual partners, violence between men, use of alcohol and drugs and 
engaging in forced sex make up part of the problem. Understanding of the broader 
economic and social factors interconnected with power and sex is required, rather 
than an examination of individual values and choices (Van Zyl, 2011). 
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 The transmission of HIV occurs when cells with CD4 molecules on their surface 
come into contact with HIV. Cells like this are found in the immune system and 
are called T-cells. T-cells are white blood cells that switch on the immune system 
to fight disease. Once the virus is inside the T-cell, HIV reproduces millions of 
these little viruses, which kill the cell and then spread to infect other cells. HIV 
causes AIDS. The virus attacks the immune system of the body and when the 
immune system is broken down, the body loses the ability to protect itself from 
serious and even deadly infections and cancers. These are called opportunistic 
infections and it is these that cause death. AIDS is the condition that allows these 
opportunistic infections to take hold. It can take months or years for an 
individual’s immune system to weaken enough for the symptoms of HIV to be 
seen. The development of symptoms is also dependent on the general health of the 
individual (Van Zyl, 2011). 
 
2.2.1.1  The Life Cycle of HIV and AIDS  
 
In order to learn the activity of Human Immunodeficiency Virus in the human 
body and what the responses of the human body are to HIV, it is important to 
know the life cycle of HIV. HIV is a retrovirus which reverses the normal flow of 
genetic information (Van Dyk, 1992). In cells where the genes are expressed, the 
genetic material is DNA. The DNA is first transcribed into a messenger RNA 
(mRNA), which serves as the template for the production of proteins. The genes 
of the retrovirus are encoded in RNA; and before they can be expressed, the RNA 
must convert into DNA. Only then are the viral genes transcribed and translated 
into proteins in the sequence (Barnett & Whiteside, 2006). The retroviruses do not 
have their own DNA as a template for the production of proteins; therefore they 
have to use the gene materials-DNA of a target cell as their template. It means 
HIV cannot multiply itself without host cells and has to use target cells for 
replication. In the human body, CD4 which are important cells controlling and 
supporting the immune system, become target cells of the HIV.  
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 After entering the body, HIV attaches to the CD4 receptors, mainly on the 
dendritic cells and T lymphocytes, as well as other cells, such as monocytes, 
macrophages and others, as long as they possess a CD4 receptor on their surface. 
Once attachment and entry into the CD4 cells have occurred, the HIV finally 
destroys the cells (Evian, 2000). 
 
2.2.1.2  The Effect of HIV on the human body  
 
Once HIV invades the human body, they survive and replicate in the human body, 
and lead to the human body’s eventual death. According to Van Zyl (2011) the 
immune system of the human body has a strong repairing ability and therefore, it 
takes a long time to develop AIDS. According to Van Zyl (2011) a person who 
becomes infected with HIV will usually go through various clinical stages that 
occur over a long period of time. According to Evian (2000), the following are the 
stages of HIV infection: 
 
I.   The Acute Phase 
 
The acute phase of HIV infection which may begin as early as a week after 
infection, it usually precedes sero-conversion, which generally develops 6 to 12 
weeks (sometimes longer) after infection. Sero-conversion means conversion 
from HIV negative to HIV positive (Van Dyk, 1992). This period is called the 
window period. HIV antibodies are usually detected after about 6 weeks. Some 
individuals may need 12 weeks, and very few may need 6-12 months before their 
HIV test becomes positive (Evian, 2000). The symptoms of the acute phase are 
fever, tiredness, rash, sore throat, muscle and joint pains and some swelling of the 
lymph glands and present for a period of (1-2 weeks) sero-conversion illness. 
According to Barnett and Whiteside (2006), during early infection period an HIV 
and AIDS test can be negative and a person is able to pass on the virus to others 
during this window period. The more people there are in the early stage of 
infection, the greater the chance of effective transmission between people. 
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 II.   The Asymptomatic Carrier Stage 
 
The second stage of HIV infection is the asymptomatic carrier stage at which a 
person infected with HIV develops antibodies, becomes a carrier of the virus for 
life, but displays no symptoms (Van Dyk, 1992). The HIV-infected person usually 
experiences a period of good health in which the virus remains clinically silent or 
latent.  The phase may last between 3 and 7 years, even up to 10 years; but the 
virus is active in the body, usually causing progressive damage to the immune 
system. The person is able to spread the virus during this phase, and the HIV test 
is positive (Van Zyl, 2011). 
 
III.   The Symptomatic Phase 
 
After about 5-8 years following HIV infection, the viral load tends to increase 
progressively and the immune system continues to deteriorate and become 
immune deficient. The most common signs and symptoms of this stage of HIV-
related disease are as follows (Evian, 2000): 
 
• Oral or vaginal Candida infection (thrush), usually persistent and recurrent 
• Hairy leukoplakia on the tongue 
• Recurrent herpes simplex infection, “cold sores” or genital herpes infection 
• Herpes zoster (shingles) 
• Acne-like bacterial skin infections 
• Persistent and unexplained fevers and night sweats 
• Skin rashes 
• Generalised lymphadenopathy or shrinking of previously enlarged lymph nodes 
• Persistent diarrhoea 
• Weight loss (more than 10% of usual body weight) 
• Reactivation of tuberculosis may also be associated with this stage of infection, 
especially in people from low socio-economic communities, where tuberculosis is 
common. 
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 IV.   The severe symptomatic phase: AIDS, severe HIV-related disease 
 
The symptomatic phase usually progresses over the next year or 18 months into 
the fully developed AIDS phase of the disease. Signs and symptoms of AIDS may 
differ from one patient to another and depending on which infection, cancer or 
organ is affected. According to Van Zyl (2011), people who are infected suffer 
from the following during this stage: 
 
• Respiratory infection usually presents with persistent cough, chest pain and 
fever. 
• Candidiasis presents with oral and or genital thrush. 
• Infection of the bowel is present with on-going diarrhoea 
• People with AIDS usually experience severe tiredness, fatigue and weakness 
• Occasionally there may be some memory and concentration loss, and some 
people may eventually develop severe mental deterioration and confusion 
 
Patients with AIDS have high HIV viral loads, or signs of HIV disease or low 
CD4 cell count, therefore risk of transmission is increased in this stage. In order to 
guide clinical treatment, the World Health Organisation set up the international 
Adults HIV and AIDS staging system (National Department of Health, South 
Africa, 2004). 
 
2.2.2 Diagnosing of HIV and AIDS 
 
During the early stage of HIV infection, in many patients there are no signs of 
HIV infection and the only evidence of HIV infection is a positive HIV test. The 
HIV antibody test is the only way to know if a person is definitely HIV infected. 
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 2.2.2.1  HIV Diagnostic Tests 
 
According to Van Zyl (2011) the following are various methods that are used to 
diagnose an HIV infection namely: HIV Antibody, HIV Antigen and HIV PCR 
tests. 
I.   HIV and AIDS Antibody Test 
 
The HIV antibody test is usually done on blood (serum) including 
ELISA（enzyme-linked immune-sorbent assay） and a western blot method of 
testing. These tests are usually done in the laboratory. With the HIV antibody test 
it is possible to detect antibodies in other body fluids such as saliva and urine. But 
the HIV antibody test does not detect the actual HIV virus. Approximately 6 
weeks after infection, antibody tests usually become positive. After HIV infection 
and before the test becomes positive, this period is called window period (Van 
Zyl, 2011)). This usually lasts 6 weeks or may last 12 weeks or 6-12 months 
depending on different patients. During the window period, although the HIV 
antibody test is still negative, the person is HIV infected and the virus can be 
passed on to others. The antigen and the HIV PCR tests are usually positive 
 
II.   ELISA Antibody Test  
 
The HIV ELISA antibody test which is the most popular and commonly used test 
and it is sufficient to make a diagnosis of HIV-infection.  
 
III.   HIV antigen and PCR tests 
 
They are commonly known as the P24 HIV antigen and the HIV RAN PCR test. 
Antigen/PCR tests usually become positive within 7-14 days after HIV infection. 
The P24 antigen test is more likely to be positive around the sero-conversion 
period and in the more advanced stages of the disease, but they are expensive and 
usually not necessary for HIV diagnosis. 
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 There is also a higher false positive rate in the very early stage of HIV infection. 
A person with AIDS will usually be dead within 1-3 years, so the prevention of 
AIDS should focus mainly on the prevention of HIV infection which is 
transmitted in different ways. Understanding of the different HIV and AIDS 
transmission modes is the first step in the prevention of the disease. These are 
discussed in detail below. 
 
2.2.3 Transmission modes of HIV and AIDS 
 
This sub-section has three important points related to HIV and AIDS transmission 
mode. 
 
2.2.3.1   HIV and AIDS is transmitted through unsafe sex 
 
In order to gain entry into the body, the HIV needs to bind to CD4 receptors, such 
as macrophages, dendritic cells and T4 lymphocytes. The receptor cells are 
plentiful in the lining of the genital tract and the ano-rectal area. Therefore anal 
and vaginal intercourse and oral sex are high risks for transmitting the HIV virus 
(Ncayo, 2012). Non-penetrative sex, such as sex between the thighs and 
masturbation, is considered safe (Ncayo, 2012). 
 
2.2.3 2   Blood and body fluid transmission 
 
HIV and AIDS can be transmitted by blood and certain body fluids Van Zyl 
(2011). 
 
I.   HIV and blood transmission. 
 
According to Evian (2000) HIV-infected blood becomes a high risk when passed 
into the body in any of the following ways: 
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 • Through a blood transfusion 
• Via blood-contaminated needles, syringes, razor blades and other sharp  
instruments 
• Through intravenous drug use (sharing of needles and syringes) 
• It is also possible, but very rare, for HIV to enter the body through an open skin 
wound  
• Nurses and healthcare professionals can become infected with HIV and AIDS 
through accidental exposure to HIV and AIDS-infected blood and body fluids. 
 
II.   HIV and body fluids transmission 
 
According to Van Zyl (2011) the following body fluids can transmit HIV: 
 
• Any body fluids containing visible blood 
• Semen 
• Vaginal secretions (including menstrual discharge) 
• Amniotic (pregnancy) fluid 
• Cerebrospinal (brain and backbone) fluid 
• Peritoneal (abdomen) fluid 
• Pericardial (heart) fluid 
• Pleural (chest) fluid 
• Synovial (joint) fluid 
 
2.2.3.3    Mother to child HIV transmission (MTCT) 
 
According to Van Zyl (2011) HIV can be transmitted from mother to child during 
pregnancy, childbirth and via breast-feeding. Individuals can protect themselves 
from contracting HIV in the following ways: abstaining from sex or having one 
partner, having safe sex, ensuring all sexually transmitted infections are treated, 
knowing their HIV status, never sharing needles and ensuring that precautions are 
taken when handling blood. 
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 Once a patient is diagnosed with HIV infection and AIDS, the next important step 
in treatment is the care of the patient. In the following paragraph, the treatment of 
HIV and AIDS will be discussed. 
 
2. 2. 4 The Treatment of HIV and AIDS 
 
At present, no cure for individuals infected with HIV has been found, in spite of 
over two decades of intensive research. Research into a cure is on-going, but due 
to the nature of the virus and its capacity to mutate, vaccine and treatment are 
difficult to develop (Ngcakaza, 2012).  There are no effective drugs that can cure 
the HIV and AIDS, but scientists have found a few drugs that can inhibit the HIV 
reproduction, thereby extending the life of the HIV infected person. Treatment is 
becoming more effective than before and the progression of the disease can be 
successfully halted. The treatment is called Antiretroviral Treatment (Van Zyl, 
2011). 
 
The South African National Department of Health have developed national 
guidelines for the use of ART in order to ensure optimal therapy and good clinical 
outcomes. There are two ART regimens for adult use in the South African Public 
Sector. Patients who fail both regimens are referred for individual evaluation by 
ART specialist (Evian, 2000). 
 
According to Van Zyl (2011) the following are the regimens that are utilised to 
manage those who are infected with HIV and AIDS:  
 
(i) Regimen 1a - (dt4 stavudine) 3TC (lamivudine) EFV (Efavarenz) 
(ii) Regimen 1b – d 4T/ 3TC/ NVP (Neviripine) 
(iii) Regimen 2 – AZT (zidovudine) ddl (Didanosine) Lopinavir/ ritonavir 
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 2.2.5 HIV and AIDS prevention 
 
Before a vaccine for HIV is developed and in the absence of any cure for HIV and 
AIDS, the prevention of HIV and AIDS transmission is the only way to combat 
the prevalence of HIV infection. There are many factors that influence the 
prevention and the spread of HIV and AIDS transmission. They are explored in 
the following paragraphs. 
 
HIV is transmitted through certain behaviour patterns. According to Van Dyk 
(1992) HIV and AIDS should not be seen as an exclusive medical problem for 
which medical science has to find an answer. The prevention of HIV and AIDS 
should include behavioural issues that can be controlled through changing high-
risk behaviour. WHO (1988) stated that effective education and information 
campaigns are the key to preventing further spread of HIV infection. 
 
The knowledge of the prevention of HIV and AIDS transmission and behavioural 
intervention are the first elements of the KAP model. While this element is not in 
itself sufficient to reduce HIV transmission, it is an essential starting point in any 
HIV prevention programme (Kalichman, Nachimson, Cherry and Williams 1998 
in Lahav, 2001). Therefore, having knowledge of the prevention of HIV and 
AIDS transmission is the starting point for the community members to prevent 
HIV transmission. This treatise is aimed at exploring the knowledge levels of the 
community members with regard Drug Resistant TB and HIV and AIDS. 
 
Secondly, the factors that led to the rapid spread of the virus include the role of 
international travel. Patient Zero, who had AIDS and was a Canadian flight 
attendant, travelled extensively worldwide and early cases of AIDS showed a link 
to the flight attendant and those affected, leading to the conclusion that 
international travel had an effect on the transmission of the virus. Blood 
transfusions are also attributed to the spread of HIV and AIDS.  
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 The routinized use of blood transfusions in the USA, as well as donors who were 
intravenous drug users being paid to donate blood, led to the spread of the virus. 
Lastly, an increase in the use and availability of heroin in the 1970s, as well as the 
accessibility and sharing of disposable plastic syringes, opened another route 
through which the virus could be spread (Ncayo, 2012). 
 
Cornelissen (2006) stated that diseases and poverty are widespread in South 
Africa and these are key factors that are contributing to the rapid spread of HIV. 
Loss of income due to medical and funeral expenses impacts on households. The 
financial impact of HIV and AIDS on a household has been shown to be 30% 
more than deaths arising from other causes. Professional health services are not 
freely available and the burden of caring for those that are infected rests with the 
family. 
 
Gender inequalities have also contributed to the fast spread of HIV and AIDS. 
South Africa has the highest level of rape in the world for a country that is not at 
war. Women are infected through rape and sometimes unable to access drugs to 
prevent HIV infection. The HIV and AIDS epidemic is mainly driven by the 
interaction of gender, sex and power relations. The effects of traditional 
masculine roles and behaviours, including men having power over women, having 
multiple sexual partners, violence between men, use of alcohol and drugs and 
engaging in forced sex make up part of the problem. An understanding of the 
broader economic and social factors interconnected with power and sex is 
required, rather than an examination of individual values and choices (Van Zyl, 
2011). 
 
2.3 Issues related to Multi Drug Resistant Tuberculosis and Extreme 
Drug Resistant Tuberculosis (MDR TB and XDR TB) 
 
This section has ten important points related to Drug Resistant Tuberculosis and 
Extreme Drug Resistant Tuberculosis (MDR TB and XDR TB). 
22 
 
 2.3.1 Definition of Drug Resistant TB and its causes 
  
Multi Drug Resistant Tuberculosis is defined as form of Tuberculosis caused by 
mycobacterium tuberculosis resistant in vitro to the effects of isoniazid (INH) and 
rifampicin (RIF) (WHO 2006a). When a strain of tuberculosis is apparently 
incurable in a patient using the more common anti-tuberculosis drugs, it is known 
as a Drug Resistant Tuberculosis. Drug Resistant TB was first reported in South 
Africa in 2005. MDR-TB strains are by definition resistant to the most potent first 
line anti-TB drugs (Isoniazid and Rifampicin) while XDR-TB strains are resistant 
to isoniazid and rifampicin plus any fluoronquinolone and at least one of the 
inject able drugs (capreomycin, kanamycin or amikacin) (WHO, 2007). 
 
Drug resistance is caused by a genetic mutation that makes a drug ineffective 
against the mutant bacilli. An inadequate or poorly administered treatment 
regimen allows a drug resistant strain to become the dominant strain in a patient 
infected with tuberculosis. On-going transmission of established drug-resistant 
strains in a population is also a significant source of new drug-resistant cases 
(WHO 2006a). 
 
Tuberculosis is an air-transmitted disease which mainly affects lungs and when 
this happens it is called Pulmonary Tuberculosis. It may affect other parts of the 
body such as brain, spine and bowel. TB is an infectious air-borne disease that is 
spread when infected people cough, spit, talk or sneeze. Those that are in close 
proximity to infected persons for long periods (Adebanjo, 2011). 
 
The Global Project was initiated in 1994 in order to estimate the global burden of 
Drug-Resistant TB worldwide using standardised methodologies. The project was 
also begun to monitor trends in resistance, evaluate the performance of TB control 
programmes and to advice on drug regimens. The report is published every three 
years as most countries require between 12 and 18 months for completion of the 
drug-resistance survey (WHO, 2008a). 
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 2.3.2 Global estimates of Multi Drug Resistant TB 
 
It is estimated that 489 139 cases of MDR-TB emerged in 2006, and the global 
proportion of resistance among all incident TB cases was 4.8%. China and India 
are estimated to carry 50% of the global burden, with the Russian Federation 
carrying a further 7%. An estimate of prevalence can be made by multiplying 
incidence by the average duration of the disease (WHO 2008a). According WHO 
(2008a) several terms are used in the Global Project as follows: 
 
1. New cases - were those patients who had never received TB treatment or who had 
received TB treatment for less than a month. In order to estimate the global and 
regional means of resistance and to examine the distribution of resistance within a 
region, data that had been collected since the beginning of the project were 
included and weighted by the population they represent to obtain the “population-
weighted mean”. 
2. Previously treated cases - refers to the presence of resistant isolates of 
mycobacterium tuberculosis in patients who in response to direct questioning, 
admit to having been treated for tuberculosis for one month or more or, in 
countries where adequate documentation is available, in a patient for whom there 
is evidence of such a history. 
3. Combined case - refers to drug resistance in the population surveyed, regardless 
of the occurrence or absence of prior treatment 
 
In the African region, six countries have reported data since 2002. A lack of 
comprehensive national drug-resistance survey data from all countries in Africa is 
a barrier to understanding the magnitude of the prevalence and incidence of 
MDR-TB The prevalence of MDR-TB remains below the levels seen in Central 
Europe and parts of Latin America. However, in Africa, the tragically high HIV 
prevalence and limited funds and infrastructure dedicated to healthcare are serious 
factors (Amor, Nemser, Singh, Sankin, & Schlunger, 2008). 
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 According to the studies that were conducted by the Medical Research Council 
National Tuberculosis Research Programme in three provinces of South Africa 
revealed a rate of approximately 1% MDR-TB in new TB cases, and 4% in 
previously treated cases. This translates to about 2 000 new cases of MDR 
tuberculosis in South Africa each year (Adebanjo, 2011). A number of MDR-TB 
cases have been reported in Kwa-Zulu Natal. The first population-based data on 
MDR-TB in KwaZulu-Natal in 1996 identified 2, 1% of sputum culture-positive 
patients as having MDR-TB in a rural district.  
 
The World Health Organisation Global Project on Anti-tuberculosis Drug 
Resistant Surveillance between 1999 and 2002 reported that in 2001 in Kwa-Zulu 
Natal, mono-drug resistance in new TB patients was 4% and in previously treated 
patients was 8%, while MDR-TB in new TB patients was 2% and in previously 
treated patients was 8% (Naidoo, Taylor & Jinabhal, 2007). 
 
In America ten countries have reported data since 2002, namely Peru, Guatemala, 
Argentina, Paraguay, Honduras, Costa Rica, Canada, Nicaragua, Uruguay and 
Cuba. The population-weighted mean of MDR-TB based on all countries that 
have reported in the American regions is 2.2% among new cases of MDR-TB, 
13.2% among previously treated TB cases and 4.0% among combined cases 
(WHO, 2008a). 
 
In the Eastern Mediterranean region, the following five countries have reported 
data since 2002: Lebanon, Jordan, Oman, Morocco and Yemen. The population 
weighted mean of MDR-TB based on all countries that have reported in the 
Eastern Mediterranean is 2.0% among new cases of MDR-TB, 35.3% among 
previously treated TB cases and 5.4% among combined cases. 
 
Based on available information, it is estimated that there were 25 475 incident 
MDR-TB cases in the region in 2006, with almost 60% of these cases estimated to 
be in Pakistan (WHO, 2008a). 
25 
 
 In the European region 32 countries have reported data since 2002. The 
population-weighted mean of MDR-TB based on all countries that have reported 
in Central and Western Europe is 9% among new MDR-TB cases, 7.7% among 
previously treated TB cases and 1.5% among combined cases. The proportion of 
MDR-TB was significantly higher in the Eastern European and Central Asian 
countries with the following population-weighted means: 10.0% MDR-TB among 
new cases, 37.7% among previously treated TB cases and 22.6% among 
combined cases (WHO, 2008a). 
 
In the Western Pacific region the following countries and two special 
administrative regions have reported data since 2002, including data from one 
province, one special administrative region and two municipalities in China, the 
Philippines and Vietnam. Of the countries indicated, Fiji, Guam, New Caledonia, 
New Zealand, the Northern Mariana Islands, Singapore, the Solomon Islands and 
Vanuatu reported the fewest cases, namely between 0 and 3 cases of MDR-TB per 
year. Australia reported 12 cases in 2005 and Macao Special Administrative 
Region in China reported nine cases of MDR-TB (WHO, 2008a).  
 
Hong Kong Special Administrative Region in China reported 41 MDR-TB cases 
in 2005 among all cases (or 1.2%), and Japan, through its sentinel survey, 
reported that 1.9% of all notified cases were MDR-TB. China, the Philippines and 
Vietnam reported higher proportions of drug resistance. The population-weighted 
mean of MDR-TB based on all countries that have reported in the Western Pacific 
region is 3.9% among new MDR-TB cases, 21.6% among previously treated TB 
cases and 6.7% among combined cases. Based on available information it is 
estimated that there were 152 694 incident MDR-TB cases in the region in 2006, 
with almost 85% of these cases estimated to be in China (WHO, 2008a). 
 
In the United States of America, HIV-positive MDR-TB cases initially had a 
100% mortality rate, but with greater awareness and earlier diagnosis, an 
improvement in initial survival rates of up to 50% has been reported. 
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 HIV-negative cases in the USA have had better response rates of between 56% 
and 69%. During an outbreak in Spain between 1991 and 1995, 47 of 48 patients 
infected died and during two outbreaks in London (Chelsea and Westminister 
Hospital, and St Thomas’s Hospital) the mortality was over 50% in HIV positive 
patients (Omerod, 2005). In South Africa, two-year case fatality rates are around 
30% to 50% (Weyer, 1999). 
 
2.3.3 Risk Factors for Drug Resistant TB 
 
Solis, Shin, Han, Llanos, Stowell and Sloutsky (2005) stated that some of the 
factors that have contributed to the number of cases of Drug Resistant TB are 
delayed diagnosis, delayed determination of drug susceptibility, and the 
susceptibility of immune-suppressed individuals not only to acquiring Drug 
Resistant TB but to rapid disease progression, which may result in rapid 
transmission of the disease to other immune-compromised patients. 
 
According to Trangle, Fallon and Awosika-Olumo (2004), resistance of 
tuberculosis to antibiotics is described as a man-made amplification of 
spontaneous mutations in the genes of the tubercle bacilli. Subsequent 
transmission of resistant strains from an infectious individual to other persons 
leads to disease that is drug-resistant from the outset, a phenomenon known as 
primary resistance.  
 
Drug resistance is more common in people who do not take their TB medicine 
regularly or who experience mal-absorption of anti-TB drugs despite strict 
adherence to the treatment regimen (Sharma & Mohan, 2007). The misuse of 
antimicrobials in the form of incorrect dosages — overprescribing, extravagant 
prescribing and under-prescribing — is commonly reported in countries such as 
Tanzania and India. As a result of an improper spacing of dosing intervals, 
efficacious serum drug levels are probably not achieved, resulting to reduced drug 
efficiency and generation of resistance against the drugs (Atre & Mistry, 2005). 
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 The treatment with a single drug due to irregular drug supply, inappropriate 
prescription or poor adherence to treatment suppresses the growth of susceptible 
strains to that particular drug but permits the multiplication of drug-resistant 
strains. This phenomenon is called acquired resistance (Adebanjo, 2011).  
 
Experiences in the developing world have revealed that traditional healers, who 
have no knowledge of pharmaceuticals, drug regulations or the side effects of 
modern drugs, still incorporate inappropriate drugs into their traditional therapy 
for clients with TB. Such practices may lead to adverse drug interactions or may 
cause side effects. This also promotes drug resistance. Perceiving no relief also 
affects the patient’s psyche and makes him or her shop around for other 
treatments (Ndoro, 2009) 
 
In Africa, other factors that might favour the development of Drug Resistant TB 
include the availability of drugs on the open market and a private sector that 
delivers drugs to the population in an unregulated fashion (Ndoro, 2009). Poor 
drug availability, the lack of clinical trials and provider inexperience had led to 
regimens commonly being incorrect or inadequate. Noncompliance to TB 
treatment could be due to poverty, gender discrimination or homelessness. Poor 
patients may have to cope with the economic demands of the illness by reducing 
expenditure on other items that are important for their health, such as food and 
water (Adebanjo, 2011). 
 
Patients may also stop treatment because they cannot afford the range of costs 
associated with continuing treatment, even when treatment itself is provided free 
of charge (Ndoro, 2011). In turn, poverty leads to under nutrition which reduces 
drug absorption, resulting in sub-therapeutic serum drug levels and non-response 
to drug therapy (Atre & Mistry, 2005). 
 
Gender issues are equally significant. A study in Russia reported “female gender” 
as a significant predictor of Drug Resistant TB. 
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 In the Indian context, harassment by in-laws, a reduction in their marriage 
options, or dismissal from work as a result of being diagnosed with TB were 
reported as major barriers for women to come forward and get appropriate 
treatment (Atre & Mistry, 2005). For males the challenges were different from 
those faced by females, as head of the family they discontinued treatment because 
of fear of dismissal and social isolation (Atre & Mistry, 2005). 
 
Increasing globalisation and population mobility will mean an increase in Drug 
Resistant TB cases (Ormerod, 2005). Migration to earn a livelihood may be 
associated with active transmission of drug-resistant strains of tuberculosis (Atre 
& Mistry, 2005). Illegal immigrants, in particular, are at risk for contracting and 
spreading Drug Resistant TB. Tourism and modern transport systems can spread 
diseases quickly from one continent to another or from one region to another. 
Civil wars and guerrilla wars are the reason for thousands of people being 
displaced from their natural environment and being placed into refugee camps. 
Not only does stress lower the resistance of the people but being over crowded 
together in (refugee camps) circumstances like these also facilitates the quick 
spread of the disease (Ndoro, 2011). 
 
2.3.4 Pathogenesis and the cause of MDR-TB 
 
Primary drug resistance is resistance to one of the first-line anti-tuberculosis 
agents in people who have not had previous treatment, and secondary or acquired 
drug resistance is resistance to one or more anti-tuberculosis agents in patients 
undergoing therapy (Adebanjo, 2011). 
 
A history of inadequate treatment, past treatment with only one drug, or a 
previous history of defaulting on treatment followed by a return of symptoms may 
be considered as reasonable suspicion that one is dealing with Drug Resistant TB 
(ICN, 2008).  
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 The improper management of Drug Resistant TB can result in further drug 
resistance. Patients with Drug Resistant TB frequently have advanced disease 
associated with thick walled cavities and chronic lung lesions that can be difficult 
for antibiotics to penetrate and therefore, they are difficult to cure and pose a 
substantial threat to household contacts and to TB control efforts (Mukherjee et 
al. 2004). 
 
2.3.5 Case-finding and diagnosis of Drug Resistant TB 
 
Delay in the diagnosis of Drug Resistant TB results in patients presenting with 
chronic disease, progressive parenchymal destruction, higher bacillary loads and 
continuing transmission (Mukherjee et al. 2004). Effective case finding is 
therefore important. A rational case-finding strategy includes accurate, timely 
diagnosis through quality-assured culture and drug-susceptibility testing. 
Programmatic strategies for the management of drug-resistant TB aim to identify 
patients and initiate adequate treatment for drug-resistant cases in a timely 
manner. Prompt identification of Drug Resistant TB and initiation of treatment 
provide a better chance of a cure for patients, provide the best infection-control 
measures and prevent the acquisition of further resistance and progression to a 
chronic state of permanent lung damage (WHO, 2006a). 
 
The diagnosis of Drug Resistant TB can only be made by showing in vitro 
resistance to isoniazid and rifampicin. Drug Resistant TB is a laboratory 
diagnosis; it is only diagnosed by TB culture and susceptibility testing 
(Department of Health, 2004). In a study conducted in Peru it was found that 
conventional Drug Sensitivity Testing (DST) methods used by most programmes 
are time-consuming, often resulting in delays of up to three or four months, 
sometimes more (Adebanjo, 2011). Susceptibility to first-line drugs can be 
determined by the Griess method in eight to 10 days after obtaining a positive 
culture (indirect method), or 21 to 28 days when applied to a smear-positive 
sputum sample (direct method). 
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 The rapid drug-sensitivity testing would reduce the opportunity for nosocomial 
transmission and the morbidity associated with delayed diagnosis of Drug 
Resistant TB (Solis et al., 2005). 
 
Patients with Drug Resistant TB face the prospect of lengthy and often unpleasant 
treatment as well as the real possibility of premature death. Therefore, counselling 
and emotional support are particularly important, much as in any other chronic 
life-threatening illness, for example malignancies or HIV-related diseases. Proper 
early counselling will also help to ensure good adherence to the treatment regimen 
and increase the likelihood of a successful outcome. Once the patient is on 
treatment, further support will be required in order to maintain adherence and to 
help identify social and emotional problems early so that they may be addressed 
before they interfere with the treatment programme. If treatment has been 
unsuccessful and further therapy becomes futile, it becomes very important that 
the patient is not merely abandoned, but continues to receive sympathetic and 
palliative care from healthcare practitioners (South Africa, 2007). 
 
2.3.6 Management of Drug Resistant TB 
 
The World Health Organisation (WHO) guidelines for the programmatic 
management of drug-resistant tuberculosis represent the best current knowledge 
in the management of MDR TB and XDR TB, and offer options for tailoring 
diagnosis and care to different epidemiological and programmatic conditions 
worldwide (WHO, 2006b). These guidelines offer updated recommendations for 
TB control programmes and medical workers in middle- and low-income 
countries faced with drug-resistant forms of TB, especially MDR-TB. The 
guidelines aim to disseminate consistent, up-to-date recommendations for national 
TB control programmes and medical practitioners on the diagnosis and 
management of drug-resistant TB in a variety of geographical, political, economic 
and social settings (Adebanjo, 2011).  
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 The guidelines can be adapted to suit diverse local circumstances because they are 
structured around a flexible approach, combining a consistent core of principles 
and requirements with various alternatives that can be tailored to the specific local 
situation (WHO, 2006b). The guidelines detail the recommended management 
protocols to enable national TB control programmes to access quality-assured, 
second-line anti-tuberculosis drugs, and to introduce new standards for 
registering, monitoring and reporting the treatment outcomes of patients with 
drug-resistant TB. This uniform information management system allowed 
systematic, consistent data collection and analysis, which played an important role 
in shaping future policies and recommendations (WHO, 2006b). 
 
Treating Drug Resistant TB patients requires experience and special expertise, 
which are available at dedicated provincial Drug Resistant TB treatment centres. 
Drug Resistant TB referral centres are regarded as centres of expertise and 
therefore remain responsible for the overall treatment of Drug Resistant TB 
patients even after discharge (South African National Department of Health, 
2011). According to Adebanjo (2011) these centres should be adequately staffed 
and equipped with appropriate infection-control interventions to prevent 
nosocomial spread of Drug Resistant TB. Patients with Drug Resistant TB should 
be admitted for at least the first six months or preferably until they have produced 
two consecutive monthly culture-negative sputa. 
 
2.3.7 Prevention of Drug Resistant TB 
 
Healthcare providers can help prevent Drug Resistant TB by diagnosing TB cases, 
following recommended treatment guidelines, monitoring patients’ responses to 
treatment and making sure that TB therapy is adhered to and completed. The 
World Health Organisation strongly advocates the use of Directly Observed 
Treatment Strategy, which was and still remained as the most cost-effective 
approach to detecting and curing cases, and preventing the onset and spread of 
drug resistance tuberculosis (WHO, 2006a). 
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 The key actions for preventing and controlling drug-resistant TB include the use 
of recommended treatment regimens, a reliable supply of quality-assured first and 
second-line anti-TB drugs, adherence to treatment by patients, and the proper 
provision of treatment by healthcare providers. A needs assessment must be 
conducted prior to implementation, in order to determine the capacity of TB 
control programmes to manage the drug-resistant TB prevention strategy (WHO, 
2006b). 
 
2.3.8 Treatment of Drug Resistant TB 
 
There are several strategies for the delivery of Drug Resistant TB treatment, 
including hospitalisation. Patients with Drug Resistant TB are more likely to have 
experienced problems with non-adherence in the past. Adherence to Drug 
Resistant TB therapy is particularly difficult because of its prolonged treatment 
regimens with large numbers of drugs that have more serious adverse effects 
(WHO, 2006a).  
 
Drug Resistant TB patients are at increased risk of non-adherence to treatment 
due to the toxic and side effects that the drugs have on patients. Adherence is an 
essential element to prevent the generation of pan-resistant strains with the 
potential for community-wide spread and virtually no possibility of a cure for the 
patients; therefore, hospitalisation is necessary initially (Adebanjo, 2011). 
 
The choice between hospitalised and ambulatory treatment depends on several 
factors in addition to the severity of the disease. Such factors include the 
availability of hospital beds, with adequate infection-control measures to prevent 
nosocomial transmission; the availability of trained personnel at hospitals and 
clinics to administer treatment and manage adverse drug reactions; the availability 
of a social support network to facilitate adherence to ambulatory treatment; and 
the presence of other clinical or social conditions in patients (WHO, 2006). 
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 The National Tuberculosis Control Programme of the Department of Health 
developed a strategy to treat patients with Drug Resistant TB in South Africa. A 
policy was developed which recommended that Drug Resistant TB treatment be 
provided as part of the National Tuberculosis Control Programme in areas where 
the Directly Observed Treatment Strategy has been implemented successfully. In 
South Africa currently provides Drug Resistant TB treatment is currently 
provided through the National Tuberculosis Control Programme structures in all 
the provinces (Adebanjo, (2011). 
 
2.3.8.1  Pharmacological Treatment of Drug Resistant TB 
 
Doctors may choose a standardised approach or an individualised approach to 
treat Drug Resistant TB. A standardised treatment regimen is when all patients in 
a defined group or category receive the same treatment regimen (WHO, 2006b). 
The design of an individualised regimen differs from that of standardised 
treatment regimens in that it is based on an analysis of the resistance pattern of the 
infecting strain of the individual patient, in addition to the patient’s treatment 
history and the prevailing resistance patterns in the community (Adebanjo, 2011). 
 
In some countries a standardised regimen for certain groups of patients may be 
more appropriate than an individualised regimen, while in others the converse 
may be best (WHO, 2006a). A Drug Resistant TB regimen consists of two phases: 
the first phase is the period in which a combination of injectable and oral 
medication is used, and the second phase occurs after the injection has been 
stopped and only oral medications are continued. 
 
The recommended duration of treatment is guided by smear and culture 
conversion. The key actions for preventing and controlling drug-resistant TB 
include the use of recommended treatment regimens, a reliable supply of quality-
assured first and second line anti-TB drugs, adherence to treatment by patients, 
and the proper provision of treatment by healthcare providers (WHO, 2006b). 
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 Sputum smear and culture conversion is defined as two sets of consecutive 
negative smear and culture taken 30 days apart (WHO, 2006a). The minimal 
recommendation is that treatment should last for at least 18 months after smear 
and culture conversion. Extension to 24 months may be indicated in patients 
defined as “chronic cases” with extensive pulmonary damage (WHO, 2008c).  
 
The following second-line drugs are used for treating Drug Resistant TB: 
 
a. Injectable anti-TB agents 
 
Injectable anti-TB agents include kanamycin, amikacin, and capreomycin. An 
injection is given to every patient in whom susceptibility is documented or 
suspected (WHO, 2006). 
 
b. Fluoroquinolones 
 
This group of drugs is used if the strain is susceptible. Examples of drugs in this 
group are ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin and gatifloxacin 
(WHO, 2006a). 
 
c. Oral bacteriostatic second-line anti-TB drugs 
 
Oral bacteriostatic second-line anti-TB agents include ethionamide, protionamide, 
cycloserine, P-aminosalycyclic acid and thiocetazone (WHO 2006a). 
 
d. Corticosteroid treatment 
 
The use of corticosteroids in MDR-TB patients can be beneficial in cases of 
severe respiratory insufficiency and central nervous system involvement (WHO 
2006a). 
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 e. Vitamins 
 
Vitamin B6 (pyridoxine) should also be given to all patients receiving cycloserine 
or terizidone to prevent adverse neurological effects. Vitamin (especially vitamin 
A) and mineral supplements can be given in areas where a high proportion of the 
patients have deficiencies. If minerals (zinc, iron and calcium) are given, they 
should be administered at a different time from the fluoroquinolones, as they can 
interfere with the absorption of these drugs (WHO, 2006a). 
 
Drug Resistant TB is generally curable or treatable but requires treatment up to 
two years using the above mentioned second line anti-TB drugs. There is also no 
guarantee that one will be cured after this period. These drugs are more costly 
than the first line drugs and they produce adverse drug reactions that are more 
severe but manageable. The treatment of MDR is very expensive and the 
prevention of MDR-TB is a serious challenge as its spread could lead to an 
incurable epidemic. XDR-TB is extremely resistant to the best second line drugs 
and XDR infected people are difficult to treat and if they are left un attended to, 
the disease will spread to the rest of the country and become difficult and very 
expensive to contain or control afterwards (WHO, 2007a). 
 
Patients with DR-TB face the prospect of lengthy and often unpleasant treatment 
as well as the real possibility of premature death. Therefore, counselling and 
emotional support are particularly important, much as in any other chronic life-
threatening illness, for example malignancies or HIV-related diseases. Proper and 
early counselling will also help to ensure good adherence to the treatment regimen 
and increase the likelihood of a successful outcome. Once the patient is on 
treatment, further support will be required in order to maintain adherence and to 
help identify social and emotional problems early so that they may be addressed 
before they interfere with the treatment programme. 
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 If treatment has been unsuccessful and further therapy becomes futile, it becomes 
very important that the patient is not merely abandoned, but continues to receive 
sympathetic and palliative care from healthcare practitioners (Adebanjo, 2011). 
 
2.3.8.2  Non Pharmacological Treatment include Surgery 
 
The most common operative procedure in patients with pulmonary DR-TB is 
surgical resection (taking out part of or the entire lung). Surgical resection has 
been shown to be effective and safe under appropriate surgical conditions. It is 
considered to be an adjunct to chemotherapy and appears to be beneficial for 
patients when skilled thoracic surgeons and excellent postoperative care are 
available. Surgery is not indicated in patients with extensive bilateral disease.  
 
Regardless of the specific procedure, surgery should be timed to offer the patient 
the best possibility of a cure with the lowest risk of morbidity. Thus surgery may 
be advised earlier in the course of the disease when the patient’s risk of morbidity 
and mortality is lower and when the disease is still localised to one lung or one 
lung lobe. Generally, at least two months of therapy should be given before 
surgical resection to decrease the bacterial infection in the surrounding lung tissue 
(WHO, 2006a). 
 
A study conducted by Pomerantz et al. (2001) revealed that during a 17-year 
period, 172 patients with MDR-TB underwent 180 pulmonary resections, that is, 
98 lobectomies and 82 pneumectomies. All patients had a minimum of three 
months of chemotherapy before surgery. Ninety-one patients were culture-
positive at the time of surgery; however, after surgery, only four patients 
remained culture-positive. 
 
a. Nutritional support 
 
According to Loveday, Thomson, Chorpa, and Ndlela (2008) Drug Resistant TB 
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 can be exacerbated by poor nutritional status, low body mass index and severe 
anaemia. Without nutritional support, patients can become enmeshed in a vicious 
cycle of malnutrition and disease, especially those already suffering from baseline 
hunger. The second-line drugs may also further decrease the appetite, making 
adequate nutrition a greater challenge. Nutritional support can take the form of 
providing free staple foods, and, whenever possible, should include a source of 
protein (Adebanjo, 2011). 
 
b. DOTS-Plus strategy 
 
DOTS-Plus for Drug Resistant TB is a comprehensive management initiative, 
built upon the elements of the Directly Observed Treatment Strategy. However, 
DOTS-Plus also takes into account specific issues such as the use of second-line 
anti-TB drugs. The goal of DOTS-Plus is to prevent further development and 
spread of Drug Resistant TB. DOTS-Plus is not intended for universal application 
and is not required in all settings. The aim of implementing the DOTS-Plus 
strategy in selected areas with significant levels of MDR-TB is to combat an 
emerging epidemic. The underlying principle is that the first step in controlling 
Drug Resistant TB is prevention by full implementation of DOTS. An effective 
DOTS-based TB control programme is a prerequisite for implementation of 
DOTS-Plus (WHO, 2004). 
 
Health care workers in primary healthcare settings are often the first people to see 
patients who present with symptoms and are thus able to identify and manage 
suspected TB and DR TB cases. Nurses working with individuals, families, 
communities and other services need to understand their role in controlling this 
preventable disease (ICN, 2008). Nurses work closely with patients and their 
families; this means that they are well placed within communities to play a crucial 
role in providing a caring environment for all patients suffering from TB. This is 
essential to the success of TB control programmes, which need to offer good 
access to effective diagnostic and treatment facilities (ICN, 2008). 
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 Socioeconomic problems should be addressed to enable patients and their families 
to adhere to Drug Resistant TB treatment. Enablers are goods or services that 
make it easier for patients to adhere to treatment, such as the provision of 
transportation vouchers and clothing. Incentives are goods or services that are 
used to encourage patients to adhere to therapy (WHO, 2006a). 
 
In relation to TB, nurses promote health in order to prevent people becoming 
vulnerable to the disease in the first place. They prevent illness by reducing 
transmission of TB in the community by finding and treating active cases, they 
restore health by ensuring that patients receive the treatment they need, and they 
alleviate suffering by organising support for patients according to their individual 
needs (ICN, 2008). 
 
2.3.9 Prevention of Transmission of Drug Resistant TB. 
 
According to Ndoro (2009) the use of face masks in high-risk settings for drug-
resistant TB is recommended for patients in order to reduce the risk of infection 
and the spread of the disease especially in high-prevalence HIV settings and 
where healthcare practitioners or workers are suspected to be HIV-infected. 
Respiratory protection may be used as an interim measure while selected 
administrative awaiting implementation. 
 
2.3.10 Management of Drug Resistant TB in the South African Context 
 
It is of utmost importance that drug-resistant TB be prevented by rigorous 
adherence to the principles of the National Tuberculosis Control Programme, and 
by patiently and consistently building partnerships with patients, their families 
and communities to cure TB on the first attempt. The framework for managing 
Drug Resistant TB includes sustained government commitment; accurate, timely 
diagnosis through quality-assured culture and drug susceptibility testing; 
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 appropriate treatment utilising second-line drugs under strict supervision and an 
uninterrupted supply of quality-assured second-line drugs; and a standardised 
recording and reporting system (Adebanjo, 2011). 
 
A person with active TB can infect an average of 10-15 people of any age each 
year. People with compromised immune systems are at an increased risk of 
contracting TB. There are, however, several drugs that can be used to cure TB 
(Whalem & Samba, 2001). In Africa, other factors that might favour the 
development of MDR and XDR-TB include the availability of drugs on the open 
market and a private sector that delivers drugs to the population in an unregulated 
fashion (Amor et al., 2008).  
 
Non-compliance to TB treatment could be due to poverty, gender discrimination 
or homelessness. Patients may also stop treatment because they cannot afford the 
range of costs associated with continuing treatment, even when treatment itself is 
provided free of charge (WHO, 2005). In turn, poverty leads to under nutrition 
which reduces drug absorption, resulting in sub-therapeutic serum drug levels and 
non-response to drug therapy (Adebanjo, 2011). 
 
2.4 Legal and ethical issues in management of the Human 
Immunodeficiency Virus and Acquired Immunodeficiency 
Syndrome and Drug Resistant Tuberculosis. 
 
According to Louw (2008) the following rights are afforded to everyone: 
• Right to non-discrimination 
• Right to privacy and confidentiality 
• Right to a healthy working environment 
• Right to continuation of employment relationship 
• Right to freedom of choice and movement. 
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 In terms of section 9 of the Constitution of the Republic of South Africa, Act 108, 
1996, People Living with HIV and AIDS are protected from potential 
discrimination. Everyone is afforded the right to equality.  Discrimination on the 
basis of race, sex, gender, pregnancy, age, sexual orientation and disability is 
regarded as an unfair discrimination. Although HIV and AIDS is not included in 
this list, it qualifies as it is analogous to include it as the employment Equity Act 
(EEA) prohibits discrimination of HIV and AIDS infected people. Also in terms 
of the Labour Relations Act (LRA) dismissals due to HIV positive status is 
prohibited and therefore regarded as automatically unfair. 
 
The Medical Schemes Act, 131 of 1998 also prohibits discrimination on provision 
of medical benefits due to HIV and AIDS status (Louw, 2008). In terms of section 
2 of the International Labour Organisation (ILO) Code of Good Practice, HIV 
should not be considered as a cause of termination of employment. Infected 
people should be afforded an opportunity to work for as long as they are 
medically fit to do so in an appropriate work. Dismissal for being HIV positive is 
prohibited in terms of the LRA and it constitute an unfair labour practices. In 
terms of the LRA Code of Good Practice, reasonable accommodation should be 
made for the infected person. The employer should make alternative and suitable 
employment to accommodate the employee (Cillie, 2008). 
 
Section 14 of the Constitution of the Republic of South Africa, Act 108 of 1996, 
affords everyone the right to privacy. The EEA prohibits testing for employment 
reasons unless such tests are justified by the Labour Court. In terms of the 
Common Law, people are prohibited from disclosing their patient’s health status 
without their consent. The code of Good Practice also states that there is no legal 
duty to disclose one’s status. Written consent should be given. 
 
The South African citizens have the right to freedom of movement and choice. In 
terms of the Occupational Health and Safety Act employers have a legal duty to 
provide a safe working environment. 
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 All necessary steps should be taken to minimise risks of occupational infections 
or injuries. Procedures that need to be followed should such events occur should 
be known and employees be assisted where possible when it comes to claiming 
when such exposures occur (Louw, 2008).  
 
MDR and XDR TB are air borne diseases. In certain circumstances the above 
mentioned rights pose a challenge when it comes to the management of these 
diseases especially here in South Africa (Ndoro, 2009). Medical Practitioners find 
themselves in an ethical dilemma of either divulging the medical condition of 
their patients for the benefit of the society or keeping up to the principle of doctor 
patient confidentially to the detriment of society (Van Niekerk, 2009).  
 
Secondly part of control measures for the spread of the MDR and XDR TB is to 
ensure that those infected are isolated and that they get minimum contact with the 
other uninfected people. This have been in certain instances challenged by 
patients as it is an infringement in their right to freedom of movement and choice 
when they refuse to take treatment and ran away from hospital to their homes. For 
family members to take precautionary measures they need to be aware or 
informed of the medical condition of their relative (Ngcebetsha, 2011). 
 
2.5 Knowledge about DR TB and HIV and AIDS 
 
Literature reviewed revealed studies that were conducted for various population 
groups despite the fact that the majority of these studies were not from South 
Africa. 
 
2.5.1 Tuberculosis or Drug Resistant Tuberculosis 
 
According to a study that was conducted in India to assess the Doctors knowledge 
of TB Management it was found that doctors that were working in the public 
42 
 
 sector had a better knowledge of TB than those who were from the private sector 
(Vandan, Prasad and Kuroiwa, 2009). Al-Maniri, Al-Rawas, Al-Amji, De Costa, 
Erikson and Diwan, (2008) in their study which they conducted to assess TB 
knowledge among General Practitioners in Oman discovered that General 
Practitioners had a low suspicion and poor knowledge of TB especially in areas of 
diagnosis, treatment, follow ups and contact screening. 
 
In another study that was investigating the knowledge, attitudes and practices of 
Private Practitioners regarding management of TB in a rural district of Sindh in 
Pakistan, it was discovered that they lacked TB diagnosis and management 
knowledge. Over 40% of them did not prescribe TB treatment regimen as 
prescribed by the TB Directly Observed Treatment Strategy category, while only 
14% of them advised sputum microscopy only for pulmonary TB diagnosis 
(Ahmed, Fatmi, Ahmed & Ara, 2009). The findings of this study are in line with 
those of a study that was conducted in Croatia where gaps in knowledge regarding 
TB knowledge among Physicians were discovered (Savicevic, 2009). 
 
In a study that was conducted in Philippines to evaluate the Physicians 
knowledge, attitudes, practices and their approach in the diagnosis and 
management of pulmonary tuberculosis gaps were found in the subjects of the 
study. 57.5% of the respondents indicated that they will just add two (2) drugs to 
the regimen and re-evaluate, while 15% said that they will just add one (1) drug 
(Yamada et al., 1999). 
 
In a study that was conducted in Rio de Janeiro, 43% of health care workers 
(HCW) were aware of the morbidity and mortality related to Drug-Resistant 
Tuberculosis. A study conducted in Vietnam, at a rural district basic health 
facility to assess the level of knowledge and practices regarding tuberculosis 
among health staff, found that HCW knowledge of theoretical aspects was better 
than knowledge related to patient management, and that even the staff members 
who had attended TB training courses had inadequate TB knowledge particularly 
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 in areas of TB control and prevention (Hoa and Thornson, 2005). A study to 
assess the knowledge and attitudes of health care providers such as doctors and 
nurses in Peruvia discovered knowledge gaps such as failure to identify patients at 
high risk for TB, assessment for treatment outcome and consequences of 
treatment failure (Keifer, Shoa, Carasquillo, Nabeta and Seas, 2009). 
 
In a study that was conducted to assess the factors that were driving the 
tuberculosis epidemic in Kwa-Zulu Natal, South Africa, it was found that poor 
knowledge about MDR-TB which was particularly as a result of lack of training 
of HCW in DR-TB, particularly its causes, modes of transmission and duration 
for treatment, and hence the increase in the disease (Naidoo, Taylo & Jinabhal, 
2007). Inadequate knowledge and understanding by clinicians of effective 
tuberculosis diagnosis and treatment leads to an increase in Drug Resistant 
Tuberculosis (Loveday, Thomas, Chopra & Ndlela, 2008). A study conducted in 
250 primary health centres throughout Iraq indicated that of the 500 health care 
workers who participated in the study 95.5% had a good knowledge about 
tuberculosis (Hasim, Kubaisy & Dulayme, 2003). 
 
According to a study that was conducted by Long et al., (2001) it was discovered 
that women were more compliant to treatment than men and they experience more 
social problems than men as in Vietnam a female would find it difficult to get 
married if she is known to have suffered from tuberculosis. In a study that was 
conducted in Limpopo Province in South Africa it was found that females were 
more knowledgeable of the disease than males (Gibson, Cane, Doering & Harns, 
2005). 
 
The following are other studies that indicate respondent’s lack of awareness and 
knowledge about transmission, prevention and treatment of Drug Resistant 
tuberculosis: 
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 According to Bennstram, Strandmark, and Diwan (2004) when someone is 
infected with TB, their families and friends no longer see the individual as a 
person, but rather TB, which is a disease within a body. Since TB is an infectious 
disease healthy people keep their distance or avoid close contact with those 
infected with TB because they fear contracting the disease and dying.  
 
In Venda culture there is a belief that a husband and a wife cannot have 
intercourse while one of them is infected with TB. This usually results in family 
and social disharmony between the married people. It is for these reasons that TB 
is regarded as a social disease that presents social challenges (Edington, Sekatane 
& Goldstein, 2002). According to Ndoro (2009) in developing countries it is 
believed that TB is an incurable and dangerous disease, which only affects the 
poor due to their unhygienic habits. These beliefs and perceptions concerning TB 
bring about social blame and shame to TB patients and thereby make TB a social 
as well as a medical challenge. 
 
People infected with TB in developing countries perceive infection with TB as a 
disgrace, as it shows that someone is poor and from a low class. TB is often 
associated with dirt, poverty, poor nutrition, smoking, alcohol and low living 
standards (Edington, Sekatane, & Goldstein, 2002).  
 
There is a belief in some communities that TB remains contagious after 
completing the prescribed course of treatment. Pregnancy is believed to reactivate 
TB infection in Punjabi community; other cultures believe that TB is form of 
punishment from God, while in Vietnam most families do not allow TB patients 
to share facilities (Long, Johansson, Diwan & Winkvist, 2001).  
 
In some communities it is believed that TB is an inherited genetic disease and 
genetic inheritance constitutes a mechanism of transmitting TB (Gibson, Cane 
Doering & Harms, 2005). 
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 In rural Philippines it was commonly believed that TB can be contracted by 
passing, an infected person on the street, sharing food, telephone, beds, or other 
facilities (Yamada, Cabellero, Matsunanga, Agustin & Magana, 1999). In the 
rural district in the Province of Limpopo in South Africa there was a strong belief 
that TB was a result of breaking cultural rules, such as abortion, or lack of 
abstinence after the death of a family member. Community members in this 
community attribute TB to spiritual causes such as punishment and sin (Edginton 
et al, 2002). 
 
2.5.2 Human Immunodeficiency Virus and Acquired Immunodeficiency 
Syndrome 
 
According to the literature reviewed (Kelly, Parker & Oyosi, 2002; Strydom, 
2002; Strydom, 2003) people are well informed or have  high knowledge levels 
concerning the most basic facts about HIV and AIDS even though there are some 
gaps of information and misconceptions about the disease. 
 
A study conducted by Coetzee (2002) to evaluate the knowledge, attitudes, 
practice and behaviour on HIV and AIDS indicated that on average the 
community members were well informed about HIV and AIDS. This study further 
indicated high levels of HIV and AIDS knowledge among youth while the elderly 
were the least knowledgeable. 35% of the respondents still held misconceptions 
about HIV and AIDS being caused by witchcraft, having sex with widows who 
have not undergone ritual cleansing or traditional healers being able to cure HIV 
and AIDS. 
 
A study conducted to evaluate knowledge, attitude and behavioural perception of 
women in Kwa-Zulu Natal towards HIV and AIDS discovered that knowledge 
levels were high Abdool-Karim (2001). The study further discovered that the high 
levels of HIV and AIDS among women did not influence their adoption of safer 
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 sex practices. Society thinks that AIDS is exclusively caused by wrong sexual 
practices. In some societies, HIV and AIDS is seen as the result of personal 
irresponsibility. People have become very judgmental and moralistic towards 
AIDS victims (Anon, 2000b). Some of the HIV negative parents prohibit their 
children from playing with children who are believed to have AIDS. HIV and 
AIDS patients are considered to be less desirable and more responsible for their ill 
health (Anon, 2001). 
 
In a study conducted by Onyango (2011) 38 % of the respondents believed that 
there was a medical solution to the problem of HIV and AIDS and 21% believed 
that there was a cure for HIV and AIDS. A study conducted by Ncayo (2012) 
among Correctional Officers revealed that 86 % of the respondents were not 
aware of the fact that HIV and AIDS have no cure. This is a cause for concern as 
it may influence risky sexual behaviour among the respondents and negating the 
efforts to fight against HIV and AIDS. 
 
Strydom (2002) respondents had high levels of knowledge regarding factual HIV 
and AIDS prevention and transmission knowledge but low levels of knowledge 
on issues that were not of general knowledge. 63% of the respondents indicated 
that condoms were not 100% effective in prevention of HIV and AIDS 
transmission. Ncayo (2012) also revealed that about 20% of the respondents did 
not know that one can have TB without being also infected with HIV and AIDS. 
More needs to be done to rectify the misconception about the association between 
the HIV and AIDS and TB. 
 
Anon (2000b) is of the opinion that, regardless of research activities or regulatory 
government actions, education must continue to be the cornerstone of efforts to 
reduce the progression of the present epidemic. Only through intensive 
educational programmes can the fatal disease be successfully prevented.  
This is also supported by Stine (1993) as he emphasised that, there is no available 
vaccine against the HIV and AIDS, but rather effective methods for preventing it. 
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 Tee and Huang (2009) examined the knowledge of HIV and AIDS and attitudes 
toward people living with HIV among the general staff of a public university in 
Malaysia. The result was that respondents showed a high level of HIV and AIDS 
knowledge, which assessed the modes of transmission. Additionally, some people 
were not able to differentiate HIV from AIDS. Dana et al., (2008) also explored 
the knowledge, attitudes, beliefs and practices related to HIV and AIDS. The 
findings of his study showed that respondents had a good knowledge about HIV 
and AIDS. 
 
According to the reviewed literature, many of the respondents had good levels of 
knowledge about HIV and AIDS and generally positive attitudes towards 
PLWHA. However, a good basic knowledge of HIV and AIDS does not 
necessarily translate into positive attitudes towards PLWHA. Chiliaoutakis et al., 
(1996) found that the higher the level of accurate knowledge about HIV and 
AIDS the lower the levels of HIV and AIDS related discrimination and 
stigmatisation, while Pirie and Coetzee (2006) in their study they found that 
education was not related to reduction of AIDS-related stigma and discrimination. 
Furthermore, Bond and Nyblade (2006) indicate that a new disease stigma has 
unfolded in Sub Saharan Africa and it is known as TB-HIV and AIDS stigma, as 
visible signs of TB have become a signal for HIV and AIDS. 
 
The current TB-HIV and AIDS stigma has made it more difficult to control HIV 
and AIDS through VCT and it had also made it difficult to control TB through 
DOTS program. Those infected with HIV and AIDS have a high risk of 
developing full blown TB and they possess higher rates of TB mortality than 
people that are not infected with TB (WHO, 2007a). The factors that are driving 
the TB-HIV and AIDS stigma have been identified to be lack of knowledge,  
judgemental attitudes, desire to  blame and shame others.  
 
48 
 
 2.6 Conclusion 
 
In this chapter the researcher had reviewed literature pertinent to Drug Resistant 
Tuberculosis and HIV and AIDS. Literature about Drug Resistant TB and HIV 
and AIDS around the world was explored in order to get a better understanding of 
the extent of the problem, the methods used to prevent the spread, and how these 
diseases are transmitted, diagnosed and treated. The next chapter will focus on the 
research method that was followed in conducting this study. 
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 CHAPTER 3 
 
METHODOLOGY 
 
3.1 Introduction  
 
This chapter will focus on the methodology of the study, which entails the type of 
research that was undertaken as well as the research design pursued. It also covers 
data collection techniques, construction of questionnaires, data analysis and 
sampling methods that have been used.  
 
3.2 Research Design 
 
According to Babbie and Mouton (2001) research design is a plan or blue print of 
how the researcher intends to conduct the research. Research design is also aimed 
at providing the results that are credible, and that means the extent to which the 
results approximate reality and are judged to be trustworthy and reasonable. In the 
research design, the researcher must specify as clearly as possible what he or she 
intends to find out and also determine the best way of doing it (Babbie & Mouton, 
2001). 
 
In quantitative research, evidence is gathered according to a specified plan, using 
formal instruments to collect the needed information (Somekh & Lewin, 2005). 
According to Burns and Grove (2005), quantitative research is the “formal, 
objective, systematic process in which numerical data are used to obtain 
information about the world”. Furthermore, this method is used to describe 
variables, examine relationships among variables and determine cause-effect 
interactions between variables. 
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 This is currently the method of choice for scientific investigations in health care 
practice and requires rigorous control to identify and limit the effects of 
extraneous variables not under study. The researcher also controls the study by 
imposing conditions on the research situation so that biases are minimized (Burns 
& Grove, 2005). 
 
In this study, the researcher wanted to establish or assess the DR TB and HIV and 
AIDS knowledge levels among community members. Secondly the researcher 
wanted to establish if whether there were any gender related differences in DR TB 
and HIV and AIDS knowledge levels among community members. Lastly the 
researcher wanted to establish if whether there were any age related differences in 
the DR TB and HIV and AIDS knowledge levels among community members. 
Furthermore, the researcher has used a quantitative research design. It was the 
best method that could be used to address the research question and the above 
mentioned aims and objectives as it uses numerical data and statistical analysis to 
make meaning of the world around us, describe variables and examine and 
determine relationships between variables.  
 
3. 3 Sampling Procedure 
 
This section has only one important point related to sampling procedure. 
 
3.3.1 Sample and Setting 
 
The sample for the present study was drawn from the residents of Ward 40 at 
Greenbushes in the Nelson Mandela Bay Municipality, Port Elizabeth. The 
researcher chose to conduct the research in Greenbushes because the Jose Pearson 
MDR and XDR TB Hospital is situated in this area. Secondly, the researcher had 
observed that the residents of this area are infected and admitted in this hospital 
and that there had been incidents of violence and ill treatment between family 
members and community towards people that are infected by Drug Resistant TB. 
51 
 
 Ward 40 is situated near the ward 39, 37, 38 and 41. Ward 40 include the 
following areas Greenbushes,  Sea view, Rocklands and St Albans and is mainly 
composed of farms, informal settlements and semi urban areas in the form of RDP 
houses. The residents are mainly living in poverty, they have low literacy levels,   
work in farms and surrounding firms, and others have social grants or child 
support grants as the main source of income.  
 
In this study, the target population was residents who were 18 years and above. 
The researcher used probability sampling to draw the sample for the present 
study. Probability sampling refers to the process in which the subjects are drawn 
from a larger population in such a way that the probability of selecting each 
member of the population is known (Babbie & Mouton, 2004). 
 
The probability sampling method that was used was random sampling. A plan of 
Greenbushes indicating number of units (1100) was utilized to select the houses to 
participate on the study. The researcher started at the first chosen house and then 
selected every tenth house from the list up until all 110 (one hundred and ten) 
houses were selected. The questionnaire was administered by the researcher. The 
researcher asked the different targeted population (18 years and older) who was 
available at that time and willing to participate in the study at the selected house 
to respond to the statements that were included in the questionnaire.  
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 The biographical data on the sample is presented in Table 1. 
 
Table 1: Biographical data of the respondents (N=100) 
Variables Frequency Percentage 
Gender 
Male 
Female 
 
47 
53 
 
47% 
53% 
Educational level 
Primary school 
High school  
Degree or diploma 
 
24 
66 
10 
 
24% 
66% 
10% 
Race   
African 
Coloured 
White 
57 
40 
3 
57% 
40% 
3% 
Employment Status 
Employed 
Unemployed 
 
62 
38 
 
62% 
38% 
 
 
Table 1 show that the majority (53%) of the respondents in this study were female while 
24% of the respondents had a primary school level. 
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 Thirty eight percent of the respondents were unemployed. The majority (57%) of 
the respondents were Africans while 40% were coloured and 3% of the 
respondents were white. 
 
Figure 1 below presents information pertaining to the age of the respondents. 
 
 
41%
26%
18%
15%
Age of the respondents
18 - 30 Years old
31 - 40 Years old
41 - 50 Years old
51 - 60 Years old
 
  Figure 1: Age of the respondents 
 
As shown in figure1, the findings revealed that 41 % of the respondents were 
between the age of 18 – 30 years old and 15% of the respondents were between 
the 51 – 60 years of age. 
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 Figure 2 below presents information pertaining to the home language of the 
respondents. 
 
 
57%
33%
10%
Language of the respondents
Xhosa
Afrikaans
English
  
  
 Figure 2: Home language of the respondents 
 
Figure 2 shows that the majority (57 %) of the respondents spoke isiXhosa as a 
home language, 33% Afrikaans and only 10% of the respondents spoke English. 
 
3.4 Data Collection 
 
This section has only one important point related to data collection procedure. 
 
3.4.1 Data collection tools 
 
For the purpose of this study, data was collected using a three point likert scale 
questionnaire. It consisted of questions in which respondents were required to tick 
to indicate if whether they agree, disagree, or are unsure with or about the 
statement. The questionnaire consisted of section A which dealt with the 
biographical details of the participants and they pertained to age, gender, 
population group, home language, highest educational qualifications, and 
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 employment status. Section B dealt with DR TB and HIV and AIDS knowledge 
levels. It is relatively economical, has standardized questions, can ensure 
anonymity and questions can be written for specific purposes (Schumacher & 
McMillan, 1993). It is further stated that questionnaires are instruments in which 
the subject responds to written questions to elicit reactions, beliefs and attitudes 
(See Annexure D). 
 
The researcher used the questionnaire as a data collection tool because of the 
following reasons: 
• Cost less in terms of time and money 
• It had standardized questions 
• Anonymity of respondents can be ensured 
• Data can be collected to many people within a limited time period 
• Have a fair degree of reliability and 
•  Data analysis can be easily done 
 
According to Leedy (1997), the questionnaire is a common instrument which is 
used to study data beyond the physical reach of the observer. Christensen (2007) 
stated that a questionnaire is a technique of collecting data whereby each person 
from the sample provides a response to a question that is posed to the entire 
sample in a predetermined order. Christensen (2007) state that reliability and 
validity of the data collected can be affected by the manner in which the 
questionnaire is structured. 
 
The researcher adapted the questionnaire through modification of the ones that 
were used in the studies by Mashabela and Mtaita (1998). The researcher tried to 
structure the questionnaire in a way that validity and reliability of the data 
collected become effective by making use of the following: 
• By clearly stating the purpose of the research 
• Completion of a pilot study that resulted in minor adjustment to the 
questionnaire 
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 • Using close ended questions in the questionnaires 
• Using clear and unambiguous language 
• Properly and accurately designing the questionnaire 
 
3.5 The Pilot Study 
 
The questionnaire that was developed for this study was piloted on 10 participants 
drawn from Greenbushes. The purpose of the pilot study was for the researcher to 
check the time it will take to complete the questionnaire and also whether the 
instructions and items were clear. Pilot studies are also conducted with an aim of 
detecting possible flaws in the measurement procedure, to identify unclearly 
formulated items and allow the researcher to notice non-verbal behavior which 
possibly may signify discomfort about the context or wording of the questions 
(Christensen, 2007). 
 
The objective of the pilot study and instructions for completing the questionnaire 
were provided in a cover letter (Annexure B). The feedback from pilot study 
resulted in minor amendments being made to the original questionnaire. After the 
pilot study the statements were reduced from 35 to 25 and only close ended 
statements were included. 
 
3.6 Validity and Reliability 
 
Validity refers to the extent to which a test measures what researcher actually 
wishes to measure, while reliability has to do with the accuracy and precision of a 
measurement procedure (Babbie & Mouton, 2004). 
 
Content validity is the accuracy with which an instrument measures the factors 
under study, that is, the content being studied has adequate coverage of the 
investigative questions guiding the study (Christensen, 2007). 
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 The researcher sought assistance from experts in research in as far as the 
assessment and the face validity of the study was concerned. Colleagues and other 
co-workers were asked to test the validity of the content of the questionnaire. A 
panel consisting of a Doctor, Clinical Program Coordinator and MDR and XDR 
TB Health Educator was used to judge how well the instrument meets the 
standards, as a way of determining content validity.  
 
3.7 Data Analysis 
 
Data collected and received were analysed by using MS Excel 2010 version and 
STATISTICA software due to its flexibility and excellent capacity for labeling 
variables. The emphasis was not for computation but to help with interpretation. 
In addition to the above, data from the questionnaires was analysed by using a 
bivariate descriptive statistical method. The data collected from the respondents 
were statistically analysed using Tables, pie charts and other statistical tools such 
as Chi-square test. The bivariate descriptive method helps to understand if two 
variables are in relationship. In this study, the researcher used the Chi-square test 
to investigate whether there was any gender and age related differences in terms 
of knowledge and awareness among the respondents. 
 
Each option on the Likert scale was given a numerical value. For instance the 3-
point rating scale had a rating from one to three. Consequently, a single score was 
calculated for each participant and this lead to the overall result. The rating was as 
follows: 3-point Likert scale: 1=Agree (True); 2= Disagree (False); 3=Uncertain 
(Unsure). For each individual item, responses were coded as correct (1); incorrect 
(0) and undecided (0) and missing data was coded 0 (Norman & Carr, 2003). 
 
Each participant yielded a knowledge score of which the range was 0-25. Higher 
scores indicated higher levels of knowledge with regard to Drug Resistant TB and 
HIV and AIDS. Subsequently, the scores were dichotomized into high knowledge 
and that is to say respondents who scored at least more than 70 % (18 to 25) were 
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 coded as having high knowledge levels (1) and below 69% (1 to 17) were coded 
as having poor knowledge.  
 
A nominal scale was used to measure the data collected. This is the simplest and 
most basic type of measurement. It uses symbols such as words or numbers to 
classify or categorise the values of a variable into groups or types (Christensen, 
2007). For the purpose of making data analysis easy in this study, the researcher 
proposed to group or categorize the following variables as such: gender was 
grouped 1 = female and 2 = male and the category of the variable age was 18-40 
years and 41-60 years.  
 
3.8 Ethical Considerations 
 
The researcher believes that it is of utmost importance that one complies with the 
professional ethics when conducting a study. According to Rose and Lawton 
(1999), ethics can be defined as a set of principles, often defined as a code or 
system that acts as a guide to conduct. Researchers have an ethical obligation to 
participants in a research or a study that is conducted. All researchers should 
adhere to, namely: 
 
• Researchers should obtain informed consent from the participants. When the 
consent is informed, participants know that they are taking part in a research 
study, and that they are doing so voluntarily. 
• Participants should not be harmed in anyway by the research conducted 
• Data should be treated confidentially 
• Participant’s rights to privacy should be respected 
• Participant’s should be debriefed 
 
In this study, the researcher obtained ethics clearance from the NMMU 
RTI/Ethics Sub-Committee before conducting this study (See Annexure A). 
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 The following ethical considerations were adhered to during the research: 
 
3.8.1 Voluntary Participation 
 
The researcher recognized the fact that the respondents were to participate at their 
own will. Permission to participate in the study was requested from the 
respondents by the researcher. The researcher informed the respondents that it 
was not a must that they participate in this study. The purpose of the study was 
clarified to the respondents so that they could be able to determine whether they 
were willing to participate or not. The respondents were informed that they were 
free to withdraw from the study when they feel like they are not comfortable to 
participate. This was done in writing through a consent letter (See Annexure C). 
 
3.8.2 No harm to the respondents 
 
The study did not expose respondents to any harm, be it physically, 
psychologically, or emotionally. The researcher made sure that the information 
required from the respondents was not embarrassing and did not have a potential 
of endangering their lives. 
 
3.8.3 Anonymity and Confidentiality 
 
The research was conducted in a manner that the participants were not in any way 
associated with the given responses. Secondly, no personally identifying 
information was asked from the respondents by the researcher. When the 
respondents felt uncomfortable to disclose some of the information that is viewed 
as sensitive by them, the researcher ensured that such responses were not forced 
from the respondents. 
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 3.8.4 Deceiving the research subjects 
 
The researcher identified himself and told the respondents about why the research 
was conducted. The researcher produced all the necessary documents to identify 
himself and explain the purpose of the study to the respondents so that the 
respondents could have an understanding of why the study was undertaken. 
 
3.9 Conclusion 
 
This chapter has covered the research methodology that was employed by the 
researcher. A quantitative research method was used. In this study random 
sampling was used to select the participants from the beneficiary list of 
Greenbushes RDP housing project. The researcher administered the research 
questionnaires to the residents of Ward 40 who were 18 years and older. 
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 CHAPTER 4 
 
RESULTS AND DISCUSSION 
 
4.1 Introduction 
 
This chapter presents the data collected and discusses the findings of the study. 
The aim of this study was to assess Drug Resistant TB and HIV and AIDS 
knowledge levels of the community members of Ward 40 in Greenbushes. The 
presentation was done through a series of Tables, charts and bivariate statistics, in 
accordance with the themes that were identified around the issues discussed in the 
literature review, which were guided by the research questions. 
 
Data collected was analysed according to the following themes: 
 
- Knowledge and awareness about Drug Resistant - TB and HIV and AIDS 
prevention. 
- Knowledge and awareness about Drug Resistant- TB and HIV and AIDS 
transmission. 
- Knowledge and awareness about Drug Resistant- TB and HIV and AIDS 
treatment and diagnosis. 
- Gender related differences in Drug Resistant TB and HIV and AIDS 
knowledge levels of the respondents. 
- Age related differences in Drug Resistant TB and HIV and AIDS knowledge 
levels of the respondents. 
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 4.2 Data presentation  
 
Data will be presented according to the themes namely prevention, transmission 
and diagnosis and treatment. 
4.2.1 Knowledge and awareness about Drug Resistant TB and HIV and AIDS 
prevention 
 
Table 2 below presents information pertaining to knowledge and awareness about 
Drug Resistant TB and HIV and AIDS prevention. 
 
Table 2: Knowledge and awareness about DR TB and HIV and AIDS 
prevention 
Statements  Male (N=47) Female 
(N=53) 
Freq. % Freq. % 
DR TB can be controlled by wearing of 
surgical mask and opening of windows. 
32 68 43 81 
The spread of DR TB can be minimised by 
avoiding or minimizing close contact with the 
infected person 
25 53 31 58 
Opening of windows and minimization of close 
contact with known HIV positive people and 
children are DR TB infection control measures 
41 87 41 77 
Abstaining and practising safe sex can reduce 
spread of HIV and AIDS 
45 96 52 98 
An expensive vaccine is available to prevent 
HIV and AIDS 
26 55 39 74 
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 Table 2 provides important details related to knowledge and awareness about 
prevention of HIV and AIDS and Drug Resistant TB. The results obtained from 
this study showed that 58% of the female respondents knew that the spread of the 
Drug Resistant TB could be minimised by avoiding close contact with the 
infected person compared to 53% of males. 
 
The findings revealed that the majority (81%) of female respondents in this study 
knew that Drug Resistant TB can be controlled by wearing mask and opening 
windows compared to 68% of the male respondents.  As shown in Table 2, the 
majority (87%) of male respondents knew that opening windows and minimizing 
close contact with known HIV positive and children was another method of 
preventing the spread of the disease, compared to 77% of the female respondents. 
Furthermore, the findings revealed that almost an equal number of both male 
(96%) and female (98%) respondents knew that abstinence and practising safe sex 
could reduce their chance of getting infected with HIV and AIDS. It is important 
to note that the majority (74%) of female respondents in this study knew that there 
was no expensive vaccine to cure HIV and AIDS while nearly half (55%) of the 
male respondents believed that such a vaccine was available. 
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 4.2.2 Knowledge and awareness about Drug Resistant TB and HIV and AIDS  
 Transmission 
 
Table 3 below presents information pertaining to knowledge and awareness about 
Drug Resistant TB and HIV and AIDS transmission.  
 
Table 3: Knowledge and awareness about DR TB and HIV and AIDS 
transmission 
Statements  Male (N = 47) Female (N = 53) 
Freq. % Freq. % 
HIV and AIDS is spread through 
unprotected sex  
47 100 53 100 
TB is spread through the air by coughing 
or sneezing 
45 96 50 94 
An HIV positive person can pass the HIV 
virus to others people even though he or 
she may not have symptoms 
38 81 46 87 
People from all races can be infected with 
HIV and AIDS. 
43 91 50 94 
HIV positive people are at high risk of 
being infected with TB 
33 70 53 100 
Only poor people get infected with TB 
and HIV and AIDS 
24 51 36 68 
 HIV positive people have more chances 
of developing TB than those who are 
HIV negative 
44 94 46 87 
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 As shown in Table 3, the findings illustrate that all the male and female 
respondents (100%) in this study knew that HIV and AIDS is spread through 
unprotected sex. The results showed that the majority (87%) of the female 
respondents knew that HIV positive person can infect other people even though 
they may not yet have sign and symptoms, compared to 83% of the male 
respondents.  
 
The findings revealed that all (100%) of the female respondents knew that HIV 
positive people are at high risk of getting infected with TB compared to 70% of 
the male respondents. The results further showed that the majority (68%) of 
female respondents knew that all people can be infected with TB and HIV /AIDS 
irrespective of their economic class or status compared to 51% of the male 
respondents. The findings illustrate that a high percentage of both male (96%) and 
female (94%) respondents knew that TB is spread through the air by coughing or 
sneezing. Furthermore, the majority (94%) of female respondents knew that 
people from all races can be infected with HIV and AIDS, compared to 91% of 
the males. 
 
The results showed that the majority (94%) of male respondents knew that HIV 
positive people had more chances of developing TB than those who are HIV 
negative, compared to 87% of the female respondents.  
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 4.2.3 Knowledge and awareness about Drug Resistant TB and HIV and AIDS 
Diagnosis and Treatment 
 
Table 4 below presents information pertaining to knowledge and awareness about 
Drug Resistant TB and HIV and AIDS diagnosis and treatment.   
 
Table 4: Knowledge and awareness about DR TB and HIV and AIDS 
Diagnosis and treatment 
 
Statements  Male (N = 47) Female (N = 53) 
Freq. % Freq. % 
HIV and AIDS can be managed by taking 
antiretroviral drugs 
37 79 49 92 
HIV and AIDS has no cure 22 47 37 70 
Antiretroviral drugs helps by reducing 
viral load  
36 77 48 91 
Antiretroviral drugs helps to increase CD 
4 count 
43 91 41 77 
TB can be cured by taking the prescribed 
medication 
47 100 49 92 
It takes long and cost more to treat MDR 
TB than normal TB 
43 91 48 91 
Drug resistant TB is caused by 
interruption in TB treatment 
16 34 35 66 
 TB treatment outcomes are assessed 
through sputum test  
30 64 52 98 
XDR TB has no cure 6 13 8 15 
Drug Resistant TB treatment is free at 
designated health centres 
31 66 48 91 
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 HIV and AIDS makes the body so weak 
that it cannot fight diseases 
46 98 48 91 
People who are infected with HIV and 
AIDS can be easily identified 
19 40 29 55 
TB is diagnosed through sputum test 33 70 47 89 
 
 
As shown in Table 4, the findings revealed that the majority (92%) of the female 
respondents knew that antiretroviral drugs are used to manage HIV and AIDS 
compared to the (79%) of the male respondents.  The majority (70%) of the 
female respondents in this study knew that there was no cure for HIV and AIDS 
compared to less than half (47%) of male respondents.  Data illustrate that all 
(100%) male respondents knew that TB can be cured by taking the prescribed 
medication, compared to 92% of the female respondents. The results showed that 
the majority (91%) of the male respondents knew that antiretroviral drugs help to 
increase the CD4 count compared to (77%) of the female respondents. 
 
In addition to the above findings, the researcher found that the majority (66%) of 
the female respondents knew that Drug resistant TB was caused by treatment 
interruption compared to only 34% of male respondents. The study showed that 
only 13% of the male respondents and 15% of female respondents knew that 
XDR TB was curable. The results showed that and equal number (91%) of both 
the males and female respondents knew that it took long and costs more to treat 
DR TB than normal TB. The results indicate that the majority (55%) of the female 
respondents knew that people infected HIV and AIDS cannot be easily identified, 
compared to 40% of the males.  
 
68 
 
 Furthermore, the findings revealed that the majority (98%) of the female 
respondents knew that TB treatment outcomes were assessed through sputum test 
compared to 64% of males. The majority (89%) of female respondents knew that 
TB was diagnosed through sputum test compared to 70% of males.  
4.2.4 Analysis of gender and age related differences in Drug Resistant TB and HIV 
and AIDS knowledge levels 
 
This section discusses about gender and age related differences in Drug Resistant 
TB and HIV and AIDS knowledge levels.  
 
4.2.4.1  Gender related differences 
 
Table 5 below presents information pertaining to gender related differences in 
relation to Drug Resistant TB and HIV and AIDS knowledge levels.   
 
 Table 5: Gender related differences 
 
Mean 
 
F 
Mean 
 
M 
Pearson Chi-
square Test 
Cohen’s 
Distrib. 
df Std.Dev.  
 
F 
Std.Dev  
 
M 
 
 
23.85 
 
 
22.09 
 
 
0.0043 
 
 
0.59 
 
 
98 
 
 
3.31 
 
 
2.64 
 
 
Table 5 above provides statistical analysis about gender related differences in 
knowledge levels of the respondents. The researcher then proposed to interpret the 
Chi-square test to see whether there was any relationship between gender and the 
knowledge of the respondents. The Pearson Chi-square test was used to determine 
in general if there was any relationship between the two variables. 
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 In this study, the Chi-square test showed that p=0.0043 or p=0.004 was below 
p=0.50. This means that male and female respondents were statistically significant 
and also showed that there was a relationship between gender and knowledge 
levels of the respondents who agreed about the statement or responses which were 
correctly answered.  
 
4.2.4.2  Age related differences 
 
Table 6 below presents information pertaining to age related differences in 
relation to Drug Resistant TB and HIV and AIDS knowledge levels.    
 Table 6: Age related differences 
   
Mean 
 
18-40 
Years 
Old 
Mean 
 
41-60 
Years 
Old 
Pearson 
Chi-square 
test 
Cohen’s 
Deviat. 
df Std.Dev.  
 
18-40 
Years 
Old 
Sts.Dev  
 
41-60 
Years 
Old 
 
 
22.60 
 
 
23.88 
 
 
0.0532 
 
 
0.48 
 
 
98 
 
 
2.88 
 
 
3.46 
 
Table 6 showed that there was no relationship between age and the knowledge 
levels of the respondents. The Chi-square test showed that p=0.0532 or p=0.053 
was above p=0.50. This means that  the group 18-40 years old and 41-60 years 
old respondents were not statistically significant and also showed that there was 
no relationship between age and knowledge in relation to respondents who agreed 
about the statement or responses which were correctly answered.  
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 4.3 Discussion of results 
 
4.3.1 Knowledge regarding DR TB and HIV and AIDS Prevention 
 
 
Table 2 showed that the respondents were knowledgeable and aware of the Drug 
Resistant TB and HIV and AIDS prevention strategies and methods. The above 
findings are in line with the findings by Strydom (2002) where it was discovered 
that the respondents scored high on knowledge questions that related to HIV and 
AIDS prevention, transmission and treatment and also in line with the findings by 
Ndoro (2009) and Coetzee (2006) where it was discovered that the community 
members were well informed about Drug Resistant Tuberculosis and HIV and 
AIDS.  
 
In South Africa there have been many World Health Organisation sponsored TB 
and HIV and AIDS awareness campaigns that are aimed at global prevention of 
TB and HIV and AIDS. Such campaigns have been carried out in both rural and 
urban areas (WHO, 2006b). 
 
Table 2 further indicated that female respondents were more knowledgeable and 
aware than male respondents of the different Drug Resistant TB and HIV and 
AIDS prevention strategies or methods. The above findings are consistent with 
the findings by Gibson et al. (2005) in which it was discovered that females were 
more knowledgeable of the diseases than males. The result showed that females 
scored high than males in four of the five questions that related prevention of 
Drug Resistant TB and HIV and AIDS which were the availability of vaccine and 
abstinence to prevent spread of HIV and AIDS, use of surgical mask and opening 
of windows as Drug Resistant TB prevention strategies. 
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 Male respondents only scored higher than females in only one out of the five 
questions which was about minimizing of close contact with infected people to 
prevent spread of the drug resistant TB. 
 
Table 2 further indicated that despite the high knowledge and awareness levels 
regarding HIV and AIDS and Drug Resistant TB prevention strategies and 
methods, there was nevertheless evidence indicating that a significant proportion 
of the respondents still lacked general knowledge about prevention of these 
diseases. The result revealed that 45% of the male and 26% of the female 
respondents did not know that there was no vaccine to prevent HIV and AIDS and 
that nearly half (47% male and 42% female) of the respondents did not know that 
the spread of Drug Resistant TB could be minimised by avoiding or minimising 
close contact with the infected person. These findings are in line with the findings 
by Edginton et al., (2002) in which it was discovered that some of the respondents 
were poorly informed about tuberculosis. One of the findings of these studies was 
that the respondents believed that TB was a disease for the poor and that it also as 
a resulting of not abstaining from sex after the death of a family member and 
witchcraft, while Onyango (2011) discovered that 38% of the respondents 
believed that there was a medical solution to the HIV and AIDS problem and 21% 
believed that there was a cure for HIV and AIDS. 
 
4.3.2 Knowledge regarding DR-TB and HIV and AIDS Transmission 
 
The results in Table 3 showed that the respondents were knowledgeable and 
aware of the Drug Resistant TB and HIV and AIDS transmission modes and 
methods. The findings in Table 3 are consistent with the findings by Strydom 
(2002) where it was discovered that the respondents scored high on knowledge 
questions that related to HIV and AIDS prevention, transmission and treatment 
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 and also in line with the findings by and Odebanjo (2011) where it was discovered 
that the community members were well informed about Drug Resistant 
Tuberculosis was transmitted. 
 
Data in Table 3 further indicated that female respondents were more 
knowledgeable and aware than male respondents of the different Drug Resistant 
TB and HIV and AIDS transmission modes or methods. The above findings are 
consistent with the findings of the study conducted by Gibson et al. (2005) in 
which it was discovered that females were more knowledgeable of the diseases 
than males. Data in Table 3 showed that females scored high than males in four of 
the seven questions that were assessing knowledge Drug Resistant TB and HIV 
and AIDS transmission modes and methods. The statements were related to the 
ability to transmit HIV and AIDS even if one does not have signs and symptoms, 
all races can be infected, HIV positive being at risk of contracting TB, and only 
poor people getting infected by HIV and AIDS. Male respondents only scored 
higher than females in only two out of the seven questions which were about HIV 
positive people standing more chances of getting infected and TB being spread 
through the air by coughing or sneezing. 
 
Table 3 further showed that despite the high knowledge and awareness levels 
regarding HIV and AIDS and Drug Resistant TB transmission modes and 
methods, there was nevertheless evidence indicating that a significant proportion 
of the respondents still lacked some important knowledge concerning 
transmission modes and methods of the Drug Resistant TB and HIV and AIDS. 
Data in Table 3 revealed that 68% of the female and 51% of male respondents 
knew that all people irrespective of their economic class or status could be 
infected by HIV and AIDS. It further showed that 30% of the male respondents 
new that HIV positive people were at risk of being infected with HIV and AIDS.  
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 19% of male and 13% female respondents did not know that an HIV positive 
person could transmit the HIV virus to other people even if they do not have the 
signs and symptoms of the disease. The results also indicated that 91% of male 
and 94% of female respondents knew that all races can be infected with HIV and 
AIDS. 
 
According to Strydom (2002) an HIV antibody test is used to ascertain the status 
of an individual in the form of either an ELISA test or a Polymerase Chain 
Reaction (PCR) test, which are both effective and reliable. Van Zyl (2011) stated 
that HIV positive people can infect others even if they do not have the signs and 
symptoms of HIV and AIDS. Symptoms that are normally associated with AIDS 
include weight loss, acute loss of appetite, fatigue, swollen lymph glands, 
persistent diarrhoea, persistent cough, brown or purple spots on the skin, white 
spots or coating in the mouth and impairment of the nervous system including 
loss of memory and dementia (Coetzee, 2006). Deacon (2005) stated that people 
with compromised immune systems are at an increased risk of contracting TB. 
The results in Table 3 are similar to those of a study by Ndoro (2009) where it 
was discovered that the respondents were aware that People Living with HIV and 
AIDS were at risk of being infected by TB. 
 
The results in Table 3 are in line with the findings by Onyango (2011) where it 
was discovered that some respondents did not know that HIV and AIDS can be 
transmitted by even those people who do not seem to present with the signs and 
symptoms but as long as one is HIV positive. The finding in Table 3 implies that 
there is a possibility that the respondents might engage in unprotected sex because 
they believe that they can protect themselves once they identify the signs and 
symptoms of HIV infection in the other person and that might be too late as they 
might be already infected by then. This finding implies that there might be some 
respondents who run the risk of spreading the virus due to lack of proper HIV and 
AIDS prevention and transmission knowledge. 
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 Data in Table 3 shows that all the respondents knew that HIV and AIDS is spread 
through unprotected sex. It is interesting to note the level of knowledge about how 
HIV and AIDS is transmitted but care should be taken in that these findings do 
not actually mean that the respondents are indeed practising safe sex but rather 
just an indication of their knowledge about safe sex. Emphasis should then be on 
encouraging the respondents to practically apply their knowledge by practising 
safe sex. This finding is in line with the findings by Abdool-Karim (2001) where 
it was discovered there were high knowledge levels among respondents but 
however that knowledge did not influence the adoption of safe sex behaviour and 
practices. 
 
4.3.3 Knowledge regarding Drug Resistant TB and HIV and AIDS    Diagnosis and 
Treatment 
 
Data in Table 4 indicated that the respondents were knowledgeable and aware of 
the Drug Resistant TB and HIV and AIDS diagnosis and treatment methods. The 
results in Table 4 are similar to those of the study by Strydom (2002) where it was 
discovered that the respondents scored high on knowledge statements that related 
to HIV and AIDS prevention, transmission and treatment and also in line with the 
findings by and Odebanjo (2011) where it was discovered that the community 
members were well informed about Drug Resistant tuberculosis was diagnosed 
treated and also in contrast to the studies by Al-Maniri et al. (2008) and Ahmed et 
al., (2009) where it was discovered that the respondents lacked knowledge of TB 
diagnosis, treatment and management. 
 
Data in Table 4 further indicated that female respondents were more 
knowledgeable and aware than male respondents of the different Drug Resistant 
TB and HIV and AIDS diagnostic and treatment methods. 
75 
 
 The above findings are consistent with the findings by Gibson et al., (2005) and 
Abdool-Karim (2001) where it was discovered that females were more 
knowledgeable of the diseases than males. Data in Table 4 showed that females 
scored higher than males in ten of the thirteen statements that were used to assess 
knowledge of Drug Resistant TB and HIV and AIDS diagnostic and treatment 
methods. The statements were related to availability of cure for HIV and AIDS, 
use and effect of antiretroviral drugs, causes of Drug Resistant TB, diagnosis and 
treatment of TB. Male respondents only scored higher than females in only two 
out of the thirteen statements which were about HIV making the body so weak 
that it cannot fight diseases and antiretroviral drugs helping to increase CD 4 
count. 
 
Table 4 further indicated that despite the high knowledge and awareness levels 
regarding HIV and AIDS and Drug Resistant TB diagnostic and treatment 
methods, there was nevertheless evidence indicating that a significant proportion 
of the respondents still lacked some important knowledge concerning diagnosis 
and treatment methods of the Drug Resistant TB and HIV and AIDS. The results 
in Table 4 show that 70% of the female and only 47% of male respondents knew 
that HIV and AIDS had no cure. Table 4 further showed that only 40% of the 
male and 55% of then female respondents new that people infected with HIV and 
AIDS cannot be easily identified. These above results are in line with the findings 
by Onyango (2011) where 38% of the respondents believed that there was a 
medical solution to the HIV and AIDS problem and 21% believed that there was 
cure for this disease, while in the study by Ncayo (2012) 86% of the respondents 
were also not aware of the fact that there was no cure for HIV and AIDS. 
According to Kaplan at el., (2004) there is no cure for individuals infected with 
HIV and AIDS in spite of over two decades of intensive research. 
 
It is significant to note that the belief that HIV and AIDS can be cured and that 
people infected with HIV and AIDS might lead to the male respondent’s 
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 deviation, irresponsibility and taking chances by involving themselves in high risk 
sexual behaviour. This might also further hamper HIV and AIDS prevention 
efforts especially since female cannot negotiate or initiate the practice of safe sex 
with their male partners due to traditional masculine roles and power relations that 
exist between men and women. 
 
Antiretroviral treatment (ARV) is used to manage HIV and AIDS in infected 
people and also on pregnant women in order to prevent mother to child 
transmission as there is still no cure for the disease (Van Zyl, 2011). The results in 
Table 4 show that the majority (91%) of female respondents knew that 
antiretroviral drugs helped in reducing viral load compared to (77%) of male 
respondents. Data in Table 4 further revealed that the majority of male 
respondents knew that antiretroviral drugs helped in increasing the CD 4 count 
compared to 77% of females. It is important to note that the belief among the 
male respondents in this study that HIV and AIDS can be cured might have been 
influenced by the availability of antiretroviral drugs which help in managing HIV 
and AIDS in infected people. This implies that more education about issues 
relating Drug Resistant and HIV and AIDS diagnosis and treatment is needed. 
 
Adebanjo (2011) also found in his study that although the respondents had good 
knowledge about Drug Resistant TB, they lacked knowledge in areas relating to 
what constitutes Drug Resistant TB, how it was diagnosed, and what is used to 
treat it and the duration of such treatment. The findings in Table 4 revealed that 
the majority (66%) of the female respondents in this study knew that Drug 
Resistant TB was caused by treatment interruption compared to only (34%) of 
male respondents.  
 
Data further show that the majority (98%) of the female respondents knew that 
treatment outcomes were assessed through sputum tests compared to 64% of the 
male respondents. 
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 Drug Resistant TB is generally curable or treatable but requires treatment up to 
two years using second line anti-TB drugs and Patients with MDR and XDR-TB 
face the prospect of lengthy and often unpleasant treatment as well as the real 
possibility of premature death (South African National Department of Health, 
2007 and WHO, 2007a). The results in Table 4 revealed that all (100%) of the 
male respondents in this study knew that TB could be cured by taking the 
prescribed medication while a few number (8%) of the female respondents did not 
know. The research results in Table 4 further revealed that few and almost an 
equal number of both male (13%) and female (15%) respondents in this study 
knew that XDR TB was curable.  
 
It is also interesting to observe the contradiction between the respondents’ 
responses regarding these above two questions. This could be due to two pertinent 
explanations. The belief that XDR TB is not curable might have been influenced 
by the observations made by some of the respondents regarding the length of stay 
of the patients that are diagnosed with these strains of TB at the designated 
facility before the decision to decentralised and deinstitutionalise treatment of 
MDR and  XDR TB. Secondly the time taken before people know that they are 
infected might be also a contributing factor to the belief that XDR TB has no cure, 
as some respondents might have observed or heard of people who die or might 
have died before they know that they were infected with MDR or XDR TB 
(Department of Health, 2011).  
 
4.3.4 Gender related differences in knowledge levels about Drug Resistant TB and 
HIV and AIDS 
 
The research findings further revealed that the female respondents were more 
aware and knowledgeable than the male respondents in this study. This could 
possibly be attributed to an exposure to health care and medical facilities. 
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 Females on average are more likely to visit health care centres or clinics and 
hospitals than males. Females visit health care centres to receive contraceptives 
and during that process they are likely to receive information about HIV and 
AIDS, TB and Diabetics (Ndoro, 2009). This has been confirmed by the fact that 
male and female responders were statistically significant as p=0.0043 (see Table 
5).  
 
4.3.5 Age related differences in knowledge levels about Drug Resistant TB and 
HIV and AIDS 
 
This finding further revealed that there were no statistically significant differences 
among respondents with regard to age and this meant that age was not in 
relationship to knowledge as p = 0.0532  (see Table 6). The above findings are 
however in contrast to the study by Hashim et al., (2004), where it was discovered 
that age was significantly associated with good knowledge. 
 
4.4 Conclusion 
 
In this chapter, the research results were discussed. Results indicated that the 
community had high levels of knowledge regarding Drug Resistant TB and HIV 
and AIDS. They further revealed that female respondents were more aware and 
knowledgeable about Drug Resistant TB and HIV and AIDS than male 
respondents and that the older respondents were more knowledgeable than the 
younger ones regarding Drug Resistant TB and HIV and AIDS. Lastly the 
research results revealed that gender was significantly related to knowledge while 
age was not significantly related to knowledge. The means for addressing areas 
where gaps were identified in knowledge are outlined in chapter five. 
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 CHAPTER 5 
  
SUMMARY, CONCLUSIONS, LIMITATIONS AND 
RECOMMENDATIONS 
 
5.1 Introduction 
 
Chapter five gives a summary of this research. Conclusions of the study based on 
the findings are outlined. Limitations associated with this research are outlined 
and finally recommendations of the study are also made. Recommendations are 
divided into two. There are recommendations for the enhancement of the 
knowledge levels of the community regarding Drug Resistant TB and HIV and 
AIDS. The second sets of recommendations are for future research. 
 
5.2 Key Findings of the study 
 
The study aimed at assessing community member’s knowledge levels regarding 
Drug Resistant TB and HIV and AIDS. This study also intended to establish 
whether there were any gender and age related differences in Drug Resistant TB 
and HIV and AIDS knowledge levels of the community members. The study was 
conducted in the Eastern Cape at Ward 40 (Greenbushes area) in Nelson Mandela 
Metropolitan Municipality. 
 
In order to solve the main problem as stated in chapter one the literature pertinent 
to HIV and AIDS and Drug Resistant Tuberculosis was reviewed. HIV and AIDS 
and Drug Resistant TB in South Africa, Asia and America, Africa, Pakistan, India 
and Afghanistan were explored. Origin, epidemiology, approaches for 
management and prevention and legal and ethical issues when managing these 
diseases were looked at, and they provided the researcher with a sound base of 
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 information which was used in trying to establish knowledge levels of community 
members regarding the two diseases. 
 
The research was conducted using a quantitative research method. A three point 
likert scale structured questionnaires with closed ended questions was used to 
collect data from 100 respondents that were randomly selected using an RDP 
housing beneficiary list for Greenbushes area as sample frame. Data collected 
were statistically analyzed using frequency Tables, chi-square test and pies. The 
results of the study were discussed in accordance to themes that were identified 
around the issues discussed in the literature review. It is important to note that the 
themes were grouped as follows prevention, transmission, diagnosis and treatment 
of HIV and AIDS and gender and age related differences in knowledge levels 
about the Drug Resistant TB and HIV and AIDS. 
 
In the empirical study, the researcher aimed at assessing Drug Resistant TB and 
HIV and AIDS knowledge levels among community members.  Concerning age 
and gender differences, the empirical results provided evidence that there was 
high Drug Resistant TB and HIV and AIDS knowledge among community 
members even though there were areas where gaps or limited knowledge was 
discovered especially among the respondents between 18-40 years old. The 
research results further reveals that females were more knowledgeable than males 
on Drug Resistant TB and HIV and AIDS issues and that the respondents between 
41-60 years old possessed more knowledge regarding Drug Resistant TB and HIV 
and AIDS than the respondents between 18-40 years old. Lastly, the research 
results revealed that there were significant differences between gender and 
knowledge and that there were no significant differences between age and 
knowledge. 
 
The results indicated that there were areas in which female respondents showed 
more knowledge than male respondents in statements related to Drug Resistant 
TB and HIV and AIDS prevention. 
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 The statements were related to wearing of surgical mask and opening of windows 
as a DR-TB prevention method, the spread of DR TB can be minimized by 
avoiding close contact with the infected person, abstaining and practicing safe sex 
can reduce spread of HIV and AIDS and lastly an expensive vaccine is available 
to prevent HIV and AIDS. Furthermore, the results revealed that there were areas 
in which male respondents showed higher knowledge levels than female 
respondents in statements related to Drug Resistant TB and HIV and AIDS 
prevention. Only one statement was related to the above finding: opening of 
windows and minimization of close contact with known HIV positive people and 
children are DR TB infection control measures. 
 
In addition to the above findings, the results indicated that there were areas in 
which female respondents showed more knowledge than male respondents in 
statements related to Drug Resistant TB and HIV and AIDS transmission. The 
statements were related to an HIV positive person can pass the HIV virus to 
others people even though he or she may not have symptoms, people from all 
races can be infected with HIV and AIDS, HIV positive people are at high risk of 
being infected with TB, and lastly only poor people get infected with TB and HIV 
and AIDS. Additionally, the results revealed that there were areas in which male 
respondents showed higher knowledge levels than female respondents in 
statements related to Drug Resistant TB and HIV and AIDS transmission.  Two 
statements were related to these statements: TB is spread through the air by 
coughing or sneezing and HIV positive people have more chances of developing 
TB than those who are HIV negative. Lastly, an interesting finding was that both 
female and male respondents were all knowledgeable to a statement related to 
HIV and AIDS is spread through unprotected sex. 
 
Furthermore, the results indicated that there were areas in which female 
respondents showed more knowledge than male respondents in statements related 
to Drug Resistant TB and HIV and AIDS diagnosis and treatment. 
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 The statements were related to HIV and AIDS can be managed by taking 
antiretroviral drugs, HIV and AIDS has no cure, Antiretroviral drugs helps by 
reducing viral load, Drug Resistant TB is caused by interruption in TB treatment, 
TB treatment outcomes are assessed through sputum test, Drug Resistant TB 
treatment is free at designated health centres, and TB is diagnosed through 
sputum test. Additionally, the results revealed that there were areas in which male 
respondents showed higher knowledge levels than female respondents in 
statements related to Drug Resistant TB and HIV and AIDS diagnosis and 
treatment.  Three statements were related to these statements: Antiretroviral drugs 
helps to increase CD 4 count, TB can be cured by taking the prescribed 
medication and HIV and AIDS makes the body so weak that it cannot fight 
diseases. Lastly, an interesting finding was that both female and male respondents 
were all knowledgeable to the same proportion as it takes long and cost more to 
treat MDR TB than normal TB.  
 
The results also showed that there were areas in which both males and female 
showed inadequate knowledge or information with regard to Drug Resistant TB 
and HIV and AIDS prevention, transmission, diagnosis and treatment. The 
statements were related to avoidance or minimizing of close contact with people 
infected with Drug Resistant TB as a method to prevent the spread of the disease, 
TB treatment interruption as the cause of Drug Resistant TB, Extreme Drug 
Resistant TB having a cure, easy identification of people infected with HIV and 
AIDS, and lastly only poor people getting infected with TB and HIV and AIDS. 
 
The study also indicated that there were areas where both males and females 
showed high knowledge levels with regard to Drug Resistant TB and HIV and 
AIDS prevention, transmission, diagnosis and treatment. The statements were 
related to abstaining and practicing safe sex as HIV and AIDS prevention 
strategies, HIV and AIDS being spread through unprotected sex, MDR-TB taking 
longer to treat than normal TB, TB being cured by taking prescribed medication, 
and HIV and AIDS being managed by taking antiretroviral drugs. 
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 In brief, the study further revealed that the respondents were highly 
knowledgeable and aware about transmission of Drug Resistant TB and HIV and 
AIDS, knowledgeable about prevention and less knowledgeable about diagnosis 
and treatment. 
 
5.3 Conclusions 
 
Conclusions drawn from this study are as follows: 
 
Greenbushes community members have high knowledge levels about Drug 
Resistant TB and HIV and AIDS. Male respondents had more gaps in terms of 
knowledge in key areas that related to Drug Resistant TB and HIV and AIDS 
prevention, transmission and diagnosis and treatment while females had high 
knowledge levels. Most of the respondents between the ages 18-40 years old were 
less knowledgeable compared to the respondents between the ages 41-60 years 
old. There were areas in which both male and female respondents showed 
inadequate knowledge regarding transmission, prevention and diagnosis and 
treatment of HIV and AIDS. The respondents were highly knowledgeable and 
aware about transmission of Drug Resistant TB and HIV and AIDS and less 
knowledgeable about diagnosis and treatment. 
 
It is important to note that lack of knowledge has a negative effect on HIV and 
AIDS prevention programs. The effectiveness of strategies to control the spread 
of Drug Resistant TB and HIV and AIDS depends on capacitating the community 
members about ways by which Drug Resistant TB and HIV and AIDS can be 
prevented, transmitted, diagnosed and treated. Education and training to the 
community members are two important tools to help improve things. More health 
education and awareness campaigns need to be embark upon and a special 
emphasis should be given to rectifying myths that the community has about these 
diseases and providing the factual information. 
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 Further analysis showed that there was a statistical significant difference between 
gender and knowledge while there was no statistical significant difference in 
between age and knowledge to Drug Resistant TB and HIV and AIDS. This 
implies that further studies will be needed to help investigate whether there are 
any differences between the above variables (gender and age) and knowledge. 
 
 5.4 Limitations of the study 
 
The following section looks at the limitations of this study. The following have 
been identified as the limitations of this study. 
 
• The study was conducted among community members in a limited area, 
namely Ward 40 in Greenbushes at Nelson Mandela Metropolitan 
Municipality. It would therefore be difficult to generalize the findings of this 
research study. 
• The value of the research findings depends on the accuracy of data collected. 
Data quality can be compromised via unrepresentativeness of the sample. The 
majority of the respondents had lived for a period of 0-5 years in the area. 
Data collection coincided with September school holidays. It is possible that 
some of the respondents had just came to Greenbushes for the September 
school holidays and therefore have limited knowledge regarding these 
diseases especially Drug Resistant TB. Some community members who left 
their homes in the morning to go to work and returned in the evening were left 
out of the study. This shortcoming was further worsened by carrying out the 
household survey during week days when most working people were at work. 
Therefore some requisite respondents were lost from the study. 
 
• Restricting the study to respondents older than 18 years limited a range of 
finding. Younger respondents would have added valuable insights to the study 
enhancing the generalizability of the findings of the study to a larger 
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 population. Despite having ethical considerations as the main factor 
influencing the selection of respondents older than 18 years old, a consultative 
approach could have been adopted to include minors from the age of 13 years 
in the study. Consultation could possibly have been made in the presence of 
the parents or legal guardians of minor respondents. 
 
5.5 Recommendations 
 
 
On the basis of the literature and the empirical study undertaken, the researcher 
would like to make the following recommendations: 
• Accurate knowledge should be provided by ensuring that educational 
materials that are produced are appropriate for the various levels of literacy. 
• To sustain the relevant knowledge about Drug Resistant TB and HIV and 
AIDS among community members, it is recommended that more relevant and 
factual information regarding these diseases be made more accessible to 
community members in their home languages. Emphasis should be on 
prevention, diagnosis and treatment of Drug Resistant TB and HIV and AIDS. 
• Development of appropriate training programs and intensifying educational 
campaigns and extension of the coverage of outreach and health promotion 
programs to include churches and workplaces, and encourage changing 
behavior of community members by increasing awareness and ensuring that 
communities are well equipped especially among male and youth. 
• Local people affected or those who are living with HIV and AIDS or those 
who have been cured with Drug Resistant TB should be involved in 
facilitation of health educational programs or  campaigns in order for them to 
share with the community  their experiences and expectations. This could 
possibly create cues to action for the adoption of positive health related 
behaviour against TB. 
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 This may increase the general level of awareness people have about these 
diseases. Role models that have survived and are living with these diseases, 
should be put forward in awareness campaigns. 
 
Future research is recommended in the following areas: 
 
• The study should be extended to all wards in the municipality. 
• A comparative study should be conducted among grade ten to twelve learners 
from the previously disadvantaged schools and the model C schools. 
• A follow up study to evaluate the impact of Drug Resistant TB and HIV and 
AIDS training in reducing negative attitudes towards people infected by these 
diseases is necessary.  
• The same study should be conducted using both qualitative and quantitative 
research method with in-depth interviews and focus group. 
 
5.6 Conclusion 
 
Chapter five gave a summary of the study. Conclusions were made based on the 
findings of the study. The limitations of the current research were identified. 
Lastly the recommendations were made by the researcher for both, those that 
capacitate and uplift community knowledge levels regarding Drug Resistant TB 
and HIV and AIDS and for future research.      
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Mr T E Fana     
8 NCAPAYI STREET 
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PORT ELIZABETH 
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Dear Mr Fana 
 
DRUG RESISTANT TUBERCULOSIS AND HIV AND AIDS: KNOWLEDGE LEVELS 
AMONG COMMUNITY MEMBERS  
 
Your above-entitled application for ethics approval served at the RTI Higher Degrees 
sub-committee of the Faculty of Arts Research, Technology and Innovation Committee. 
We take pleasure in informing you that the application was approved by the Committee. 
The Ethics clearance reference number is H/12/ART/PGS-0025, and is valid for three 
years, from 01 August 2012 – 01 August 2015.  Please inform the RTI-HDC, via your 
supervisor, if any changes (particularly in the methodology) occur during this time.  An 
annual affirmation to the effect that the protocols in use are still those for which approval 
was granted, will be required from you.  You will be reminded timeously of this 
responsibility. 
 
We wish you well with the project.  
 
Yours sincerely 
 
 
Mrs N Mngonyama 
FACULTY ADMINISTRATOR 
 
cc: Promoter/Supervisor 
 HoD 
 School Representative: Faculty RTI 
• PO Box 77000 •  Nelson Mandela Metropolitan University 
• Port Elizabeth • 6031 •  South Africa •  www.nmmu.ac.za 
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 Annexure B 
       8 Ncapayi Street 
       New Brighton 
       Port Elizabeth 
Dear Colleague 
 
Pilot Study: Research about Drug Resistant TB and HIV and AIDS: Knowledge 
Levels Among Community Members. 
 
I am currently researching Knowledge Levels of Community members towards People 
Infected by drug resistant TB and HIV and AIDS. I am conducting this research to fulfil 
the requirements for MPA at Nelson Mandela University. 
 
I would appreciate your assistance in completing the enclosed questionnaire. You may 
answer all the questions and also mark all those that are ambiguous or difficult to answer. 
Criticism regarding the length, layout, language and the content will be highly 
appreciated. You can fax the completed form back to me at 041- 372 1987 before the 30th 
August 2012.  
 
Your inputs will be used to determine if whether any adaptations need to be made before 
the questionnaire can be used to the intended target population. 
 
Please note the following: 
Your participation is confidential and there are no right or wrong answers 
All personal information that is required in Section A is only required to summarize and 
correlate the conclusions of the study in a proper manner  
 
Thank you for your cooperation 
 
TE Fana     Professor Thoko Mayekiso 
Researcher     Research Supervisor 
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 Annexure C 
 
NELSON MANDELA METROPOLITAN UNIVERSITY 
INFORMATION AND INFORMED CONSENT FORM 
 
AN ASSESSMENT OF DRUG RESISTANT TUBERCULOSIS AND HIV AND 
AIDS: KNOWLEDGE LEVELS AMONG COMMUNITY MEMBERS. CONSENT 
FORMS TO BE COMPLETED BY PARTICIPANTS 
 
You have been selected to participate in a research study conducted by Thanduxolo 
Elford Fana who is studying Masters in Public Administration from the School of 
Governmental and Political Studies at the Nelson Mandela Metropolitan University.  
 
You are hereby requested to give consent for participation in the study. 
 
1. PURPOSE OF THE STUDY 
The purpose of this study is to assess Drug Resistant TB and HIV and AIDS knowledge 
levels among community members. 
 
2. PROCEDURES 
All community members will be informed of the research study that will be undertaken 
and the procedure that will be followed to select the participants. 110 out of 1100 
households will be selected for the purpose of this study using random sampling method. 
A questionnaire which will be administered by the researcher will be used to collect data. 
Respondents or (community members who are 18 years and above) will be expected to 
answer the questions that will be asked by the researcher while he fills the answers on the 
questionnaire. 
 
3. POTENTIAL RISKS AND DISCOMFORTS 
There are no risks in this study as respondents are expected to answer the questionnaire 
only. 
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 4. POTENTIAL BENEFITS TO THE RESEARCH SUBJECTS OR SOCIETY 
No direct benefit will be gained by participating in this study expect the fact that 
respondents will have an opportunity of doing reality regarding their Drug Resistant TB 
and HIV AND AIDS knowledge levels, attitudes. 
 
5. PAYMENT FOR PARTICIPATION 
There will be no financial rewards for participating in this research. 
 
6. CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential, and will only be disclosed only with your permission 
or as required by the law. Confidentiality will be maintained by means of alpha numerical 
coding which will be used. Secondly there will be no personally identifiable information 
that will be asked or required on the questionnaires. Data will be stored electronically on 
the computer and also in a memory stick once questionnaires are filled and collected. 
This information will be locked in a safe in which only the researcher will have access to. 
The information collected will only be released through a written report after proper 
analysis is done in a form of a research report or theses. 
 
7. PARTICIPATION AND WITHDRAWAL 
The participants have a choice to participate in the study or not to participate. The 
participant can refuse to answer any question that they don’t want to answer and still 
remain in the study. The participant can immediately withdraw from participating in the 
study anytime should she or he feel uncomfortable participating on it. The researcher can 
also ask the participant to withdraw from the study should his or her conduct be 
unsatisfactory. 
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 8. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact  
 
The researcher: Mr Thanduxolo Fana 
8 Ncapayi Street  
New Brighton 
Port Elizabeth 
Cell Number  : 0732301771 
Work number  : 041 3728000/6 
Fax number  : 041 372 1987 or 8007 
Email address  : 0760654543@vodamail.co.za  
 
The Research Supervisor: Professor Thoko Mayekiso 
Deputy Vice Chancellor: Research and Engagement 
Nelson Mandela Metropolitan University 
P. O. Box 77000 
Summer stand 
Port Elizabeth 
Contact Number : 041 5042016/7 
Fax Number  : 041 5042885 
Email address  : thoko.mayekiso@nmmu.ac.za or nozuko.ngcukana@nmmu.ac.za 
 
 
9. RIGHTS OF THE RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without 
penalty. You are not waiving any legal claims, rights or remedies because of your 
participation in this research study. If you have questions regarding your rights as a 
research subject, contact the Division of Research Development at NMMU. 
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 SIGNATURE OF RESEARCH SUBJECT 
 
 
The information above was described to me by Thanduxolo Fana in English and Xhosa 
and I am in good command of these languages. I was also given the opportunity to ask 
questions and these questions were answered to my satisfaction. 
 
I hereby consent to participating in this study. I have received (been given) a copy of this 
form 
 
 
 
…………………………………… 
Name of the participant 
 
 
 
…………………………………… 
Signature of participant    
 
 
…………………………………… 
Date 
 
 
 
SIGNATURE OF THE RESEARCHER 
 
 
I, Thanduxolo Fana declare that I have explained the information contained (given) in 
this document to the research subject or participant. I have encouraged and gave him or 
her ample time to ask me any questions with regard to the above. This conversation was 
conducted in English and Xhosa and no translator was used. 
 
 
 
………………………………………... 
Signature of the researcher 
 
 
 
………………………………………… 
Date 
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 Annexure D  QUESTIONNAIRE 
 
SECTION A: BIOGRAPHICAL – INFORMATION 
 
Please answer all the questions by ticking in the appropriate box 
1. Gender 
Male Female 
 
2. Age 
18 - 30 31- 40 41 - 50 51 - 60 
 
3. Racial group 
African Coloured White Other 
 
4. Home language 
Xhosa Afrikaans English Other 
 
5. Are you currently employed? 
Yes No 
 
6. What is your highest educational qualification? 
Primary High school Diploma/Degree Honours Masters 
 
7. How long have you stayed in this area? 
0 to 5 years More than 5 to 10 
years 
More than 10 to 15 
years 
More than 15 to 20 
years 
104 
 
 SECTION B : DRUG RESISTANT TB AND HIV AND AIDS KNOWLEDGE 
Statements relating to knowledge and awareness about 
Prevention of Drug Resistant TB and HIV AND AIDS  
True Uncertain False 
1. DR TB can be controlled by wearing of surgical mask 
and opening of windows. 
   
2. The spread of DR TB can be minimised by avoiding 
or minimizing close contact with the infected person 
   
3. Opening of windows and minimization of close 
contact with known HIV positive people and children 
are DR TB infection control measures 
   
4. Abstaining and practising safe sex can reduce spread 
of HIV and AIDS 
   
5. An expensive vaccine is available to prevent HIV and 
AIDS 
   
Statements relating to knowledge and awareness about 
Transmission of Drug Resistant TB and HIV and AIDS 
True Uncertain False 
1. HIV and AIDS is spread through unprotected sex     
2. TB is spread through the air by coughing or sneezing    
3. An HIV positive person can pass the HIV virus to 
others people even though he or she may not have 
symptoms 
   
4. People from all races can be infected with HIV and 
AIDS. 
   
5. HIV positive people are at high risk of being infected 
with TB 
   
6. Only poor people get infected with TB and HIV and 
AIDS 
   
7. HIV positive people have more chances of developing 
TB than those who are HIV negative 
   
Statements relating to knowledge and awareness about True Uncertain False 
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 Treatment & Diagnosis of Drug Resistant TB and HIV 
and AIDS 
1. HIV and AIDS can be managed by taking 
antiretroviral drugs 
   
2. HIV and AIDS has no cure    
3. Antiretroviral drugs helps by reducing viral load     
4. Antiretroviral drugs helps to increase CD 4 count    
5. TB can be cured by taking the prescribed medication    
6. It takes long and cost more to treat MDR TB than 
normal TB 
   
7. Drug resistant TB is caused by interruption in TB 
treatment 
   
8. TB treatment outcomes are assessed through sputum 
test  
   
9. XDR TB has no cure    
10. Drug Resistant TB treatment is free at designated 
health centres 
   
11. HIV and AIDS makes the body so weak that it 
cannot fight diseases 
   
12. People who are infected with HIV and AIDS can be 
easily identified 
   
13. TB is diagnosed through sputum test    
 
THANK YOU FOR TAKING TIME TO PARTICIPATE IN THIS STUDY 
 
RESEARCHER: MR THANDUXOLO FANA 
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